hg_52839.1

Basic information about the TSS

---

TSS ID: hg_52839.1 Species: human Chr: chr4		Start: 82374143 End: 82374199 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000507010.5 ENST00000503822.1 Distance: 0 GeneID: 3184 HGNC/MGI_ID: HGNC:5036 UniProt_ID: D6RAF8 D6RBQ9

Gene_name: heterogeneous nuclear ribonucleoprotein D Gene_symbol: HNRNPD Gene_synonyms: Gene_source: HGNC:5036

TATA-Box annotation

---

Distance to TSS:	-175
Nearest PromoterID:	NM_031369
Entrez ID:	3184
Nearest Unigene:	Hs.480073
Nearest Refseq:	NM_002138
Nearest Ensembl:	ENSG00000138668
Gene Name:	heterogeneous nuclear ribonucleoprotein D
Gene Alias:	AUF1|AUF1A|HNRPD|P37|hnRNPD0
Gene Description:	heterogeneous nuclear ribonucleoprotein D
Gene Type:	protein-coding
CpG%:	0.08
GC%:	0.60199
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	5(TCCTTTTAAAGG,-,0.00),6(CCTTTTAAAGGC,+,0.00),7(CTTTTAAAGGCC,+,0.00),51(AGGTATAAAGGG,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@HNRNPD p2@HNRNPD p3@HNRNPD p4@HNRNPD p5@HNRNPD p6@HNRNPD p7@HNRNPD p8@HNRNPD p9@HNRNPD
Sample		p1@HNRNPD	p2@HNRNPD	p3@HNRNPD	p4@HNRNPD	p5@HNRNPD	p6@HNRNPD	p7@HNRNPD	p8@HNRNPD	p9@HNRNPD
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	133.44	4.09	0.97	0.78	0.58	0.97	16.56	15.39	2.14
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	144.66	3.03	2.02	1.42	0.81	1.01	13.56	11.53	2.83
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	149.69	3.67	2.12	1.93	1.35	0.77	14.66	12.54	6.56
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	113.73	3.33	0.83	1.46	0.21	0.21	8.11	13.72	2.49
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	122.16	2.47	2.25	0.90	0.00	0.67	11.92	18.00	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	105.63	3.10	1.36	1.74	0.78	0.78	10.08	15.31	2.33
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	148.81	5.23	1.96	1.74	0.87	0.87	13.94	14.82	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	137.82	4.12	1.21	1.94	0.00	0.73	12.60	11.38	1.94
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	124.38	4.27	1.07	1.92	0.21	0.85	9.83	13.68	1.92
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	145.49	6.96	1.16	1.74	0.00	1.16	13.91	13.91	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	108.33	5.66	0.40	1.21	0.40	0.81	11.72	10.91	2.83
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	114.24	6.50	0.00	2.03	0.00	0.00	9.35	11.38	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	74.47	0.81	0.32	0.16	0.32	0.48	0.32	0.16	4.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	59.99	0.30	0.15	0.15	0.00	0.15	0.75	0.00	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	60.38	1.10	0.22	0.00	0.44	0.22	0.22	0.00	1.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	46.78	0.75	2.01	0.00	0.75	0.00	0.00	0.75	1.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	41.06	0.44	0.87	0.00	0.00	0.00	0.44	0.00	2.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	47.67	0.42	1.27	0.00	0.84	0.84	0.84	0.42	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	53.85	1.07	1.07	0.53	0.53	0.53	0.00	0.53	1.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	69.96	0.75	0.90	0.15	0.75	0.15	0.75	0.15	1.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	74.71	1.34	0.67	0.00	0.13	0.13	0.40	0.67	2.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	61.80	0.86	0.69	0.17	0.17	0.00	1.04	0.17	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	59.85	0.90	0.78	0.13	0.26	0.00	0.65	0.26	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	62.85	0.49	0.24	0.00	0.49	0.73	1.46	0.73	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	60.89	1.55	0.77	0.52	0.26	0.00	0.52	0.52	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	61.40	2.22	0.32	0.00	0.32	0.32	0.63	0.32	2.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	62.09	1.10	0.55	0.00	0.00	0.00	0.00	0.00	1.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	85.81	1.41	0.71	0.24	0.71	0.00	1.41	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	63.96	0.97	0.16	0.16	0.65	0.00	1.13	0.32	2.58
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	76.01	0.90	0.18	0.18	0.18	0.72	0.90	0.36	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	46.68	1.26	1.05	0.00	1.05	0.00	0.42	0.42	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	50.02	0.78	0.20	0.20	0.20	0.20	0.39	0.59	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	41.78	0.42	0.21	0.21	0.42	0.21	0.42	0.00	4.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	59.54	0.82	0.49	0.16	0.49	0.16	0.33	0.00	3.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	61.33	1.31	0.00	0.19	0.00	0.19	0.56	0.56	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	57.49	0.77	0.19	0.00	0.00	0.38	0.38	0.00	1.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	69.69	1.02	0.41	0.20	0.20	0.20	1.64	0.61	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	46.14	0.40	0.40	0.20	0.20	0.20	0.60	1.01	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	51.59	2.43	0.81	0.27	0.00	0.27	1.08	0.54	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	56.65	1.44	0.00	0.00	0.00	0.48	0.48	0.24	2.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	55.05	0.71	0.47	0.00	0.00	0.00	0.47	0.47	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	63.97	2.05	0.00	0.29	0.15	0.29	0.29	0.73	2.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	64.53	1.27	0.21	0.00	0.00	0.00	1.69	0.42	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	48.95	0.52	0.35	0.17	0.00	0.00	1.05	0.70	2.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	56.42	1.20	0.80	0.00	0.00	0.20	0.60	0.20	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	49.09	0.47	0.70	0.47	0.93	0.70	0.70	0.00	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	46.30	0.48	0.24	0.24	0.24	0.00	0.24	0.72	2.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	59.91	1.79	0.00	0.89	0.00	0.00	0.30	0.00	2.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	44.76	0.96	0.48	0.00	0.00	0.24	0.24	1.20	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	56.62	1.01	0.00	0.00	0.20	0.20	1.42	0.20	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	40.79	0.82	0.82	0.20	0.00	0.00	1.02	0.41	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	45.14	2.22	0.89	0.22	0.22	0.22	0.22	0.44	1.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	307.83	0.00	0.00	0.00	13.99	0.00	0.00	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.84	1.06	0.00	0.35	0.00	0.00	0.71	0.71	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	32.48	1.33	0.99	0.00	0.00	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	125.00	5.03	6.71	0.84	5.03	4.19	0.00	0.84	31.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	80.83	1.84	0.46	0.46	0.00	0.46	0.00	0.46	2.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	34.68	1.62	0.00	0.00	0.32	0.00	0.32	0.97	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.76	0.96	0.00	0.64	0.32	0.00	0.64	0.64	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	104.36	2.83	0.31	0.31	0.31	0.31	1.57	1.26	3.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	32.43	0.71	0.71	0.00	0.00	0.00	0.00	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	28.60	0.00	0.56	0.00	0.00	0.00	0.56	0.56	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	108.28	2.39	3.18	0.80	2.39	0.80	2.39	0.80	15.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	60.48	1.02	1.02	0.00	0.00	0.00	0.68	0.68	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	20.15	1.95	0.00	0.00	0.00	0.00	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	32.66	0.35	0.35	0.35	0.00	0.00	0.00	0.35	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	323.28	16.16	0.00	16.16	16.16	0.00	0.00	0.00	64.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	300.10	15.79	15.79	0.00	7.90	7.90	0.00	0.00	63.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	40.46	0.49	0.49	0.00	0.00	0.49	0.00	0.98	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	33.72	1.98	0.00	0.00	0.00	0.99	0.00	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	35.18	1.41	0.94	0.47	0.00	0.00	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	77.50	1.66	0.33	0.00	0.33	0.00	0.33	0.33	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	31.86	0.62	0.31	0.00	0.00	0.00	0.00	0.00	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	38.52	1.83	0.61	0.31	0.00	0.31	0.31	0.00	0.61
Adipocyte - breast, donor1	11376-118A8	37.22	0.95	0.00	0.16	0.00	0.00	0.32	0.48	0.32
Adipocyte - breast, donor2	11327-117E4	48.77	1.44	0.64	0.16	0.64	0.16	0.80	0.48	2.41
Adipocyte - omental, donor1	11473-119C6	39.95	0.89	0.38	0.13	0.13	0.13	0.25	0.51	0.25
Adipocyte - omental, donor2	11474-119C7	32.89	0.75	0.00	0.00	0.75	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	41.53	1.67	0.67	0.33	1.00	0.00	0.67	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	38.28	1.28	0.00	0.00	0.00	0.00	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	28.59	0.00	0.00	1.10	0.00	0.00	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	74.97	0.45	0.00	0.00	0.00	0.00	0.90	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	62.04	0.87	0.52	0.17	0.52	0.00	0.52	0.87	0.70
Adipocyte differentiation, day04, donor1	13019-139D4	151.57	0.59	0.39	0.00	0.00	0.20	1.56	0.98	0.39
Adipocyte differentiation, day04, donor2	13022-139D7	99.09	0.26	0.26	0.00	0.26	0.26	1.54	1.54	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	120.43	3.35	0.28	0.28	0.00	0.00	0.56	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	114.04	1.76	0.00	0.00	0.00	0.59	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	127.73	3.06	0.40	0.72	0.24	0.32	1.29	1.05	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	101.67	1.94	0.32	0.65	0.00	0.32	0.65	0.32	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	92.24	1.60	0.00	0.53	0.00	0.00	0.00	1.60	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	101.27	1.67	0.00	0.00	0.00	0.00	1.11	1.11	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	74.86	2.91	0.00	0.83	0.42	0.00	0.42	1.66	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	74.34	2.01	0.00	1.00	0.50	0.50	0.50	1.26	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	64.14	1.96	0.00	0.00	0.00	0.00	0.98	0.33	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	55.11	4.57	0.30	0.61	0.30	0.30	0.61	0.91	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	142.54	1.99	1.10	0.88	0.44	0.44	1.33	2.21	1.10
Alveolar Epithelial Cells, donor2	11590-120G6	103.99	1.43	0.36	1.08	0.72	0.36	1.08	2.15	1.43
Alveolar Epithelial Cells, donor3	11671-122G6	58.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	137.27	1.80	0.18	0.54	0.00	0.54	2.70	0.90	0.90
Amniotic Epithelial Cells, donor2	11613-122A2	125.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.35
Amniotic Epithelial Cells, donor3	11694-123A2	114.64	1.64	0.82	0.00	0.00	0.41	1.03	1.44	0.21
Anulus Pulposus Cell, donor1	11248-116E6	131.48	0.69	0.57	0.11	0.34	0.11	1.03	0.34	0.57
Anulus Pulposus Cell, donor2	11463-119B5	81.55	0.49	0.00	0.49	0.00	0.73	1.22	0.00	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	75.93	0.00	0.90	0.00	1.35	0.00	0.00	0.90	3.15
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	65.12	0.43	0.00	0.00	0.87	0.00	0.43	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	66.35	0.00	0.00	2.14	4.28	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	67.26	1.20	0.90	0.30	0.60	0.00	0.60	0.30	1.49
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	93.58	0.00	0.00	0.00	0.00	0.00	1.26	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	42.24	0.00	0.00	0.00	0.00	0.66	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	63.35	1.30	0.65	0.00	0.65	0.00	0.32	0.65	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	83.98	1.46	0.00	0.00	0.49	0.97	1.94	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	42.76	0.00	0.59	0.59	1.19	1.19	0.59	1.19	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	69.30	1.88	0.75	0.00	0.00	1.51	0.38	1.51	1.88
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	58.78	0.73	0.73	0.00	0.00	0.00	0.00	0.73	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	45.14	1.25	0.00	0.00	0.00	0.00	1.25	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	58.65	0.82	0.00	0.00	0.00	0.00	0.99	0.16	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	69.60	0.00	0.00	0.00	0.00	0.00	0.00	1.36	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	44.78	0.30	0.45	0.00	0.15	0.00	1.06	0.45	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	75.55	0.54	0.54	0.00	0.00	1.07	2.14	0.00	2.68
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	68.02	0.94	0.94	0.38	0.00	0.76	1.13	0.38	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	60.14	0.80	0.53	0.27	0.27	0.53	0.53	0.53	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	64.38	0.98	0.00	0.00	0.00	0.00	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	77.62	1.00	0.50	0.17	0.17	0.33	0.83	0.33	0.83
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	48.03	1.20	2.40	1.20	0.00	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	106.20	7.08	0.00	0.00	0.00	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	72.04	0.34	0.34	0.00	0.00	0.51	1.89	1.37	0.51
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	41.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	80.58	0.49	1.94	0.00	0.49	0.00	1.94	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	79.68	0.38	0.38	0.00	0.38	1.14	0.76	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	59.36	2.42	1.21	0.00	0.00	1.21	0.00	0.00	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	72.96	1.14	0.00	0.00	0.57	1.14	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	62.85	1.28	0.64	0.64	1.07	0.00	0.64	0.64	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	48.00	0.26	0.77	0.26	0.52	0.26	0.52	0.77	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	64.28	1.41	0.00	0.00	0.00	0.94	0.94	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	59.17	0.32	1.29	0.32	0.00	0.32	0.64	0.96	0.64
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	39.24	0.00	0.00	0.71	0.71	0.71	0.71	0.71	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	53.82	0.00	0.00	0.00	0.00	0.58	0.58	0.58	1.75
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	64.43	0.00	0.30	0.00	0.60	0.00	0.90	0.30	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	42.77	0.00	1.19	0.00	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	73.74	0.51	0.51	0.00	0.00	0.00	3.05	1.02	2.03
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	73.60	0.25	1.53	0.00	2.04	0.25	2.55	1.27	2.04
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	40.66	0.64	1.27	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	73.79	0.43	0.43	0.00	0.00	0.00	2.59	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	59.70	0.42	0.64	0.00	0.42	1.06	1.27	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	56.84	0.58	0.58	0.00	0.29	0.00	0.29	1.45	0.58
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	77.47	0.00	1.89	0.00	0.00	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	66.28	1.02	0.00	0.17	0.00	0.51	0.85	1.02	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	39.38	0.00	0.00	0.00	2.32	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	80.28	2.11	4.23	0.00	0.00	2.11	2.11	0.00	2.11
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	65.61	0.00	0.64	0.00	0.43	0.21	0.86	0.21	1.07
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	55.35	0.60	0.00	0.00	0.00	0.60	0.00	0.00	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	72.90	1.46	0.00	0.00	0.73	0.00	2.19	1.46	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	65.98	0.92	0.23	0.23	0.46	0.46	1.15	0.69	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	63.76	0.00	2.55	0.00	0.00	2.55	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	38.39	0.76	0.25	0.00	0.00	0.51	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	72.67	1.03	0.62	0.21	0.62	0.21	1.65	0.62	0.41
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	53.24	0.92	0.31	0.00	1.22	0.61	0.31	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	71.22	0.48	0.48	0.00	0.48	0.48	1.43	0.96	4.78
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	58.54	0.44	0.67	0.00	0.00	0.22	0.44	0.89	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	0.00	3.05	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	67.02	1.66	0.00	0.00	0.00	0.00	3.32	1.11	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	63.55	0.79	0.26	0.26	0.26	0.26	1.59	0.00	1.06
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	57.42	1.09	1.09	0.73	0.36	0.36	0.73	0.00	1.45
Astrocyte - cerebellum, donor1	11500-119F6	246.74	2.70	0.74	0.74	0.25	0.37	1.11	5.28	1.11
Astrocyte - cerebellum, donor2	11580-120F5	206.93	2.40	0.17	0.34	0.68	0.17	1.71	3.77	1.20
Astrocyte - cerebellum, donor3	11661-122F5	144.10	1.89	0.63	0.63	0.21	0.00	2.31	0.63	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	290.72	2.44	0.35	1.05	0.35	1.39	2.44	1.74	0.70
Astrocyte - cerebral cortex, donor2	11316-117D2	368.52	6.63	2.75	0.81	2.43	2.43	4.53	3.88	3.88
Astrocyte - cerebral cortex, donor3	11392-118C6	326.81	8.20	1.49	1.79	1.19	0.60	5.37	3.43	2.09
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	657.49	10.09	4.24	1.83	1.72	1.83	10.55	8.95	5.96
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	713.73	9.65	3.13	2.51	1.63	1.00	11.15	13.41	6.14
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	678.23	10.70	2.84	2.62	1.37	1.14	10.92	13.54	3.87
Basophils, donor1	12241-129G9	116.91	1.83	0.26	0.26	0.26	0.00	1.31	0.26	0.26
Basophils, donor2	12242-129H1	207.82	2.89	1.08	0.36	0.72	0.00	1.44	1.08	0.36
Basophils, donor3	12243-129H2	158.46	1.91	0.44	0.59	0.00	0.15	0.44	0.44	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	63.82	0.00	0.22	0.65	0.00	0.22	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	73.15	2.74	0.00	0.91	0.00	0.00	1.37	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	67.16	0.63	0.00	0.00	0.63	0.63	2.51	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	96.28	1.87	0.21	0.62	0.42	0.21	1.87	0.83	0.21
Bronchial Epithelial Cell, donor6	11461-119B3	78.99	0.46	0.00	0.00	0.23	0.46	0.92	0.23	1.15
Bronchial Epithelial Cell, donor7	11769-123I5	81.16	3.06	0.90	0.36	0.36	0.18	1.08	0.54	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	378.83	4.33	1.44	0.82	0.41	0.41	6.49	7.42	3.30
Burkitt's lymphoma cell line:RAJI	10476-106I8	399.20	2.56	2.56	0.23	1.40	1.40	3.03	3.49	4.43
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	301.55	2.24	0.96	0.32	0.00	0.32	4.16	2.56	0.96
CD133+ stem cells - cord blood derived, pool1	12223-129E9	475.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	210.21	1.13	0.56	0.00	0.00	0.00	0.56	1.13	0.56
CD14+ Monocytes, donor2	11305-117B9	239.24	6.12	0.74	0.56	0.93	1.11	2.04	0.56	2.78
CD14+ Monocytes, donor3	11381-118B4	199.12	1.98	0.44	0.44	1.76	0.44	0.44	0.88	2.20
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	149.16	3.68	0.57	0.85	0.00	0.00	0.57	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	124.34	1.52	0.00	0.00	0.00	0.00	0.38	0.00	0.38
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	153.52	1.31	0.00	0.00	0.00	0.00	0.66	0.99	0.33
CD14+ monocytes - mock treated, donor1	11863-125A9	148.89	2.46	0.43	0.00	0.14	0.87	1.59	0.29	2.31
CD14+ monocytes - mock treated, donor2	11873-125C1	106.52	1.81	0.30	0.60	0.30	0.00	0.00	0.91	1.81
CD14+ monocytes - mock treated, donor3	11883-125D2	113.00	1.66	0.47	0.00	0.24	0.24	0.71	0.71	1.18
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	107.80	3.35	0.84	0.33	1.00	0.50	1.00	0.84	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	94.40	1.66	0.00	0.55	0.55	0.55	0.55	2.21	2.48
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	103.39	2.48	0.25	0.00	0.00	0.25	0.74	1.24	1.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	110.04	1.57	0.39	0.20	0.98	0.59	0.98	0.20	1.37
CD14+ monocytes - treated with BCG, donor2	11870-125B7	87.78	1.60	0.36	0.00	0.18	0.36	0.36	0.71	2.14
CD14+ monocytes - treated with BCG, donor3	11880-125C8	68.77	1.31	0.00	0.00	0.00	0.44	0.65	1.31	0.87
CD14+ monocytes - treated with Candida, donor1	11868-125B5	131.81	3.98	0.70	0.47	0.70	0.23	0.70	1.17	1.17
CD14+ monocytes - treated with Candida, donor2	11878-125C6	143.62	2.64	0.00	0.00	0.00	0.00	0.53	1.58	1.06
CD14+ monocytes - treated with Candida, donor3	11888-125D7	110.94	3.33	0.00	2.22	0.00	0.00	1.11	3.33	5.55
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	110.82	2.23	1.04	0.15	1.04	0.45	0.59	1.19	2.97
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	80.62	1.80	0.80	1.00	0.00	0.20	1.80	0.80	1.80
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	70.79	1.87	0.42	0.00	0.00	0.00	0.42	0.83	1.46
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	142.30	2.75	0.23	0.46	0.00	0.46	2.06	1.14	1.83
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	95.91	1.13	0.45	0.23	0.23	0.00	1.36	0.45	1.81
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	90.35	0.44	0.44	0.00	0.00	0.44	0.44	1.31	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	121.85	1.34	0.81	0.27	0.54	0.00	0.81	0.54	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	112.70	1.74	0.70	0.00	0.17	0.35	0.87	0.70	2.97
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	111.10	2.95	0.00	0.00	0.84	0.00	1.26	0.84	1.26
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	126.76	3.67	2.20	0.18	1.65	0.73	0.73	1.10	5.14
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	123.29	3.17	0.70	0.35	0.35	0.70	0.70	0.70	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	95.64	3.07	0.00	0.00	0.44	0.44	0.44	1.32	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	108.29	2.44	0.70	0.00	1.57	1.05	0.35	0.87	3.49
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	107.41	1.49	1.12	0.00	0.74	0.37	0.37	0.37	5.95
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	98.51	2.37	0.86	0.22	0.43	0.00	0.43	0.65	0.86
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	133.49	2.46	0.82	0.82	0.00	0.00	1.23	0.41	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	93.65	1.85	0.93	0.23	0.00	0.23	0.93	0.46	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	77.95	2.55	0.23	0.23	0.00	0.23	0.93	0.93	2.55
CD14+CD16+ Monocytes, donor1	11789-124B7	66.91	2.18	0.00	0.00	0.22	0.00	0.65	0.22	1.09
CD14+CD16+ Monocytes, donor2	11801-124D1	117.81	2.31	1.39	0.00	0.00	0.46	0.46	0.00	0.69
CD14+CD16+ Monocytes, donor3	11912-125G4	73.43	1.30	0.65	0.43	0.00	0.22	0.43	0.43	0.65
CD14+CD16- Monocytes, donor1	11788-124B6	126.60	3.58	1.40	0.16	0.16	0.31	0.31	0.47	0.93
CD14+CD16- Monocytes, donor2	11799-124C8	141.46	2.45	1.22	0.35	0.35	0.00	0.52	0.35	0.70
CD14+CD16- Monocytes, donor3	11910-125G2	191.08	2.90	0.45	0.67	0.00	0.00	0.22	1.11	1.11
CD14-CD16+ Monocytes, donor1	11790-124B8	88.80	1.02	0.77	0.00	0.00	0.00	0.77	0.51	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	90.02	2.63	0.88	0.00	0.22	0.44	0.88	0.88	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	87.80	1.68	1.89	0.00	0.21	0.42	0.21	0.21	0.42
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	174.78	4.06	0.00	2.03	0.00	0.00	2.03	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	203.39	2.03	1.36	0.00	0.00	0.00	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	255.79	2.07	1.04	0.00	1.04	0.00	2.07	1.04	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	254.79	2.67	0.53	0.00	1.07	0.00	1.07	0.53	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	339.87	3.75	0.00	0.00	0.54	0.54	3.22	2.68	1.07
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	188.82	0.00	1.40	0.00	0.00	0.00	0.70	0.70	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	261.19	2.35	3.14	0.00	0.78	0.00	0.00	0.78	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	286.07	5.27	2.64	0.00	2.64	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	232.60	0.82	1.64	1.64	0.82	1.64	2.47	2.47	5.75
CD19+ B Cells, donor2	11624-122B4	185.71	2.18	0.73	0.00	1.45	0.73	0.00	0.73	8.71
CD19+ B Cells, donor3	11705-123B4	209.00	2.02	1.51	0.50	0.00	1.01	1.01	0.50	7.07
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	734.58	21.82	3.23	2.02	2.83	13.33	4.85	6.06	1.62
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	563.68	15.58	1.20	0.80	0.80	6.79	3.60	4.39	2.00
CD34+ Progenitors, donor1	11545-120B6	52.21	0.00	0.00	0.00	0.00	1.00	1.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	202.81	1.12	0.56	0.00	0.00	0.00	1.69	3.37	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	290.46	3.01	1.50	0.00	0.75	0.75	3.01	2.25	1.88
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	315.23	4.06	0.90	0.00	0.45	0.45	3.83	3.16	1.13
CD4+ T Cells, donor1	11225-116C1	418.83	2.50	1.07	0.36	0.00	0.71	1.79	1.43	1.43
CD4+ T Cells, donor2	11306-117C1	306.79	1.84	4.29	0.61	3.06	7.96	4.29	0.00	6.12
CD4+ T Cells, donor3	11382-118B5	265.04	1.52	2.44	0.30	1.83	2.44	4.27	0.61	3.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	155.69	1.79	2.04	0.51	0.00	0.00	1.02	0.26	1.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	172.94	1.35	1.57	0.00	0.22	0.90	0.90	1.35	1.12
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	193.46	1.72	0.29	0.00	0.29	0.00	0.86	0.29	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	187.27	0.95	1.90	0.00	0.00	0.00	0.95	0.95	0.95
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	197.35	0.70	0.70	0.00	0.70	0.00	1.40	0.00	6.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	178.00	3.30	0.00	0.00	0.00	3.30	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	130.93	1.01	0.72	0.00	0.14	0.43	0.87	1.16	1.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	195.39	1.86	2.03	0.00	0.85	0.68	0.34	0.34	1.86
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	177.49	0.97	1.29	0.00	1.45	0.32	1.29	0.32	1.61
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	132.25	2.69	0.00	0.00	0.45	0.00	0.45	1.34	0.90
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	131.02	2.10	0.00	0.00	0.35	0.70	0.35	0.35	1.40
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	183.91	1.32	1.32	0.44	0.44	0.00	1.76	1.32	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	189.74	1.26	0.00	0.00	0.84	0.84	2.11	1.26	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	215.04	2.70	2.70	0.42	0.62	1.04	1.25	2.08	2.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	205.15	2.00	1.00	0.33	1.34	0.67	2.34	0.67	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	193.35	2.18	1.36	0.27	0.27	0.00	0.54	0.82	0.54
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	177.40	1.61	0.54	0.00	1.07	0.54	1.07	0.00	2.14
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	215.19	1.79	1.79	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	239.57	1.67	1.48	0.19	0.56	1.48	1.67	0.74	2.23
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	168.75	1.52	0.43	0.00	0.65	0.00	2.17	1.73	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	197.54	1.89	1.05	0.00	0.21	0.42	0.63	0.84	1.05
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	151.18	1.01	2.02	0.00	0.00	0.00	1.01	0.51	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	187.60	2.60	1.73	0.00	0.00	0.00	2.60	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	215.73	0.87	1.31	0.00	0.00	0.87	0.00	0.44	1.74
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	240.51	0.99	0.00	0.00	0.49	0.00	0.99	0.49	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	185.56	0.92	1.85	0.00	0.92	0.00	1.85	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	212.17	0.00	1.40	0.00	4.19	0.00	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	349.76	1.94	0.83	0.00	0.00	0.28	2.49	1.66	0.83
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	342.81	2.94	0.98	0.00	0.74	0.49	0.98	0.49	2.21
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	204.82	0.00	0.00	0.00	1.54	0.00	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	296.16	1.43	1.07	0.36	0.72	0.00	0.72	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	299.16	0.00	2.77	0.00	0.00	0.00	2.77	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	306.11	0.98	0.98	0.33	0.33	0.98	1.96	2.95	0.33
CD8+ T Cells, donor2	11307-117C2	301.10	2.25	4.51	0.38	3.00	1.88	3.38	0.00	6.38
CD8+ T Cells, donor3	11383-118B6	339.35	2.02	2.52	0.00	2.52	0.50	3.28	2.52	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	133.28	1.15	2.06	0.23	0.69	0.69	0.92	2.52	4.13
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	131.32	2.40	1.20	0.00	0.72	1.20	2.40	4.55	3.35
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	129.41	1.64	1.37	0.55	1.64	1.37	2.74	3.83	1.92
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	157.91	0.90	0.90	0.30	0.00	0.90	2.10	2.70	3.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	115.19	0.96	0.96	0.72	0.96	0.24	1.20	1.92	5.04
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	115.06	1.14	0.45	0.00	0.23	0.00	2.27	1.59	0.91
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	160.57	1.96	0.65	0.00	0.87	0.00	2.17	4.35	1.30
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	155.55	2.90	0.79	0.00	0.26	0.79	2.11	5.26	1.58
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	162.75	1.64	1.41	0.00	0.23	0.47	3.05	5.63	3.05
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	187.47	2.11	2.42	0.00	1.51	0.60	4.23	3.92	5.43
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	179.82	2.61	0.87	0.00	1.45	0.87	4.94	6.68	3.20
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	164.12	1.60	0.00	0.00	0.53	0.00	3.46	3.73	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	109.00	1.31	0.00	0.00	0.00	0.44	1.75	3.06	1.31
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	92.45	1.37	0.00	0.00	0.46	0.91	0.91	2.28	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	93.98	2.24	0.00	0.75	0.00	0.00	0.00	3.73	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	126.41	0.72	0.72	0.36	0.36	0.00	2.88	1.80	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	125.73	1.44	0.86	0.00	0.29	1.15	1.15	2.01	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	130.34	1.41	0.24	0.24	0.71	0.00	2.36	2.59	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	193.31	1.90	1.27	0.00	1.58	0.63	2.22	4.12	1.27
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	173.77	0.31	0.62	0.92	0.00	1.23	2.15	4.92	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	173.44	1.28	0.96	0.00	0.32	0.32	2.56	7.05	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	169.05	2.29	0.00	0.38	0.00	0.00	2.68	4.59	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	147.79	1.97	0.79	0.00	0.39	0.39	2.36	4.34	1.58
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	141.45	1.51	0.00	0.00	0.76	0.00	3.03	5.29	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	203.15	4.01	0.00	0.80	0.80	0.80	2.41	2.41	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	194.44	0.70	0.00	0.70	0.70	0.70	2.10	2.10	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	166.29	1.00	0.00	0.00	0.00	0.00	2.00	5.01	2.00
Cardiac Myocyte, donor1	11525-119I4	115.15	0.00	0.00	0.00	0.00	0.00	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	145.76	2.47	0.49	0.00	1.48	0.49	2.47	0.99	4.94
Cardiac Myocyte, donor3	11686-122I3	147.75	1.37	0.84	0.21	0.32	0.00	1.37	1.05	0.21
Chondrocyte - de diff, donor1	11261-116G1	124.80	0.69	0.69	0.00	0.69	0.00	1.39	2.08	1.39
Chondrocyte - de diff, donor2	11338-117F6	45.84	0.36	0.00	0.00	0.00	0.00	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	109.00	1.37	1.02	0.34	0.34	0.34	1.37	0.34	0.68
Chondrocyte - re diff, donor2	11339-117F7	50.13	2.69	0.00	0.00	0.90	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	76.03	0.81	0.40	0.40	0.40	0.00	0.81	0.81	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	243.75	7.23	1.72	0.57	0.69	0.46	2.30	1.84	1.72
Ciliary Epithelial Cells, donor2	11323-117D9	189.18	6.41	2.99	0.43	1.92	0.64	2.78	2.78	2.57
Ciliary Epithelial Cells, donor3	11399-118D4	207.97	4.42	1.06	0.80	1.15	0.62	3.10	2.04	2.83
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	173.77	8.07	0.46	0.73	0.00	0.37	1.19	2.11	0.64
Corneal Epithelial Cells, donor1	11526-119I5	95.29	2.42	0.88	0.00	0.00	0.22	0.88	0.44	0.66
Corneal Epithelial Cells, donor2	11606-120I4	103.52	2.28	0.00	0.00	1.14	0.00	1.14	1.14	2.28
Corneal Epithelial Cells, donor3	11687-122I4	153.89	3.83	1.28	0.51	0.77	0.51	2.30	2.81	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	84.36	1.32	0.33	0.00	0.33	0.17	0.83	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	78.54	1.89	0.00	0.32	0.00	0.00	0.00	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	86.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.71	0.86	0.54	0.11	0.43	0.11	0.54	0.43	0.65
Dendritic Cells - plasmacytoid, donor1	11228-116C4	262.04	0.34	0.68	0.34	0.34	1.02	0.34	1.02	0.68
Dendritic Cells - plasmacytoid, donor2	11309-117C4	184.11	2.61	0.00	0.65	1.31	0.00	0.00	1.31	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	250.68	0.48	0.97	0.00	0.48	0.48	0.48	0.48	0.48
Endothelial Cells - Aortic, donor0	11207-116A1	159.60	1.17	0.17	0.33	0.00	0.17	1.33	2.67	0.83
Endothelial Cells - Aortic, donor1	11263-116G3	112.07	1.17	0.00	0.00	0.00	0.00	0.59	2.93	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	160.63	1.70	0.85	0.85	0.28	0.00	3.68	2.83	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	99.08	1.97	0.00	0.39	0.79	0.39	1.18	1.57	0.39
Endothelial Cells - Artery, donor1	11264-116G4	148.93	2.62	0.00	0.87	0.00	0.29	4.36	2.04	0.29
Endothelial Cells - Artery, donor2	11341-117F9	304.92	4.47	2.12	0.47	0.24	1.65	4.24	7.53	4.71
Endothelial Cells - Artery, donor3	11413-118E9	184.60	1.93	0.35	0.35	0.00	0.18	3.16	3.86	0.70
Endothelial Cells - Lymphatic, donor1	11236-116D3	97.31	1.55	0.22	0.44	0.00	0.00	0.66	1.55	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	88.24	1.22	0.00	0.30	0.30	0.00	0.61	1.52	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	103.74	1.41	0.28	0.28	0.00	0.00	1.69	0.28	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	153.32	1.49	0.59	0.30	0.00	0.00	1.78	2.38	0.59
Endothelial Cells - Microvascular, donor2	11342-117G1	66.65	0.00	0.52	0.00	0.00	0.00	0.52	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	119.53	0.99	0.71	0.14	0.71	0.57	0.85	0.99	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	332.10	2.00	0.40	0.80	0.00	0.80	4.40	4.40	2.00
Endothelial Cells - Thoracic, donor2	11343-117G2	149.90	0.00	0.52	0.00	0.00	1.05	0.52	3.14	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	390.88	4.47	1.62	0.99	0.99	0.87	4.35	7.95	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	289.18	3.91	0.65	0.65	1.52	0.43	5.43	4.78	1.09
Endothelial Cells - Umbilical vein, donor3	11400-118D5	345.01	3.30	0.37	1.71	1.22	0.61	5.86	7.94	1.10
Endothelial Cells - Vein, donor1	11267-116G7	101.24	1.14	0.00	0.00	0.00	0.00	2.28	5.69	0.00
Endothelial Cells - Vein, donor2	11344-117G3	162.75	0.00	0.00	0.00	0.00	0.00	0.70	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	174.12	1.57	0.63	0.63	1.41	0.47	2.67	4.24	0.63
Eosinophils, donor1	12244-129H3	91.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	227.74	16.50	1.65	0.00	1.65	0.00	1.65	0.00	0.00
Eosinophils, donor3	12246-129H5	196.18	10.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	78.18	0.24	0.24	0.00	0.24	0.00	0.49	0.49	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	27.04	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	74.71	0.41	0.41	0.00	0.41	0.41	0.82	0.41	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	22.01	0.66	0.22	0.00	0.22	0.33	0.44	0.44	0.00
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	73.89	0.98	0.76	0.33	0.11	0.43	1.73	1.30	0.43
Fibroblast - Aortic Adventitial, donor1	11245-116E3	161.06	2.18	0.73	0.24	0.97	0.49	2.30	1.21	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	86.52	2.05	0.27	0.68	0.00	0.27	0.96	1.64	0.41
Fibroblast - Aortic Adventitial, donor2	11326-117E3	88.17	0.74	0.84	0.42	0.42	0.21	1.48	1.37	1.90
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	146.24	1.84	0.53	1.05	0.00	0.26	0.79	2.11	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	183.04	1.00	2.33	0.00	1.33	0.00	3.65	2.66	2.66
Fibroblast - Cardiac, donor1	11268-116G8	127.92	0.91	0.45	0.45	0.00	0.91	1.81	4.08	0.91
Fibroblast - Cardiac, donor2	11345-117G4	125.06	0.00	0.76	0.76	0.76	0.00	1.52	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	93.37	3.79	0.63	0.32	0.32	0.32	2.52	2.05	0.95
Fibroblast - Cardiac, donor4	11452-119A3	183.08	0.91	0.30	0.30	0.00	0.00	2.73	2.42	0.30
Fibroblast - Cardiac, donor5	11456-119A7	161.68	1.14	0.63	0.25	0.38	0.25	1.65	1.14	1.14
Fibroblast - Cardiac, donor6	11460-119B2	156.14	1.97	0.76	0.45	0.61	0.00	1.21	1.06	2.12
Fibroblast - Choroid Plexus, donor1	11492-119E7	123.67	0.94	0.40	0.13	0.40	0.13	1.07	1.34	0.27
Fibroblast - Choroid Plexus, donor2	11572-120E6	108.72	1.29	0.43	0.00	1.73	0.00	0.86	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	270.99	4.39	2.93	4.39	2.93	5.86	2.93	7.32	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	285.30	0.46	0.46	1.61	0.23	0.00	0.92	1.38	1.15
Fibroblast - Conjunctival, donor3	11692-122I9	143.49	0.68	0.00	0.00	0.17	0.51	1.02	0.34	0.17
Fibroblast - Dermal, donor1	11269-116G9	106.83	1.41	0.70	0.23	0.47	0.23	1.88	0.70	0.47
Fibroblast - Dermal, donor2	11346-117G5	148.11	1.42	0.47	0.47	0.47	0.00	2.36	1.89	0.00
Fibroblast - Dermal, donor3	11418-118F5	144.58	0.97	1.21	0.24	0.60	0.36	1.69	0.60	1.33
Fibroblast - Dermal, donor4	11450-119A1	316.53	4.86	1.70	1.36	0.79	0.68	4.63	4.30	3.62
Fibroblast - Dermal, donor5	11454-119A5	320.65	4.88	1.40	1.05	1.05	0.87	4.01	6.11	2.27
Fibroblast - Dermal, donor6	11458-119A9	362.04	3.90	2.11	1.46	0.49	1.14	3.74	7.80	2.92
Fibroblast - Gingival, donor1	11237-116D4	131.60	1.25	0.42	0.62	0.42	0.21	1.04	1.87	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	137.55	2.36	0.00	0.79	0.52	0.26	1.83	1.31	0.26
Fibroblast - Gingival, donor2	11318-117D4	277.01	5.14	2.37	2.11	1.19	0.40	2.24	3.03	3.03
Fibroblast - Gingival, donor3	11394-118C8	139.13	0.58	0.48	0.10	0.29	0.39	1.06	0.19	0.87
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	111.16	3.12	0.00	1.04	0.00	0.00	0.00	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	100.08	1.94	0.35	0.53	0.70	0.70	1.23	1.06	1.59
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	210.15	2.34	0.31	0.78	0.62	0.62	4.68	3.43	0.62
Fibroblast - Gingival, donor6 (control)	11922-125H5	174.44	1.49	0.41	0.41	1.08	0.54	2.43	3.52	0.54
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	255.13	3.53	0.00	0.00	0.00	0.00	2.47	5.29	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	150.92	1.02	0.58	0.29	1.02	0.29	3.36	2.19	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	193.76	3.27	0.95	0.14	0.41	0.41	3.41	3.55	0.82
Fibroblast - Gingival, donor8 (control)	11926-125H9	258.22	3.18	0.77	1.10	0.33	0.66	6.47	7.90	1.97
Fibroblast - Gingival, donor9 (control)	11927-125I1	134.41	1.32	0.44	0.15	0.29	0.15	1.32	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	100.59	1.36	0.00	0.00	0.00	0.00	4.08	1.36	1.36
Fibroblast - Lung, donor2	11347-117G6	195.47	2.98	1.49	0.00	0.00	0.00	0.00	1.49	1.49
Fibroblast - Lung, donor3	11419-118F6	322.67	4.22	1.06	0.42	1.48	0.21	2.74	3.80	2.11
Fibroblast - Lymphatic, donor1	11506-119G3	219.08	2.50	0.00	0.00	0.00	0.00	0.83	3.33	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	88.11	2.80	1.40	0.00	0.00	0.00	1.40	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	59.89	1.96	0.00	0.00	0.28	0.56	1.12	1.12	0.28
Fibroblast - Mammary, donor1	11540-120B1	293.52	4.87	0.41	0.41	0.00	0.41	2.84	3.65	0.00
Fibroblast - Mammary, donor2	11620-122A9	215.69	0.00	0.00	0.00	0.00	0.00	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	142.95	5.96	0.00	0.00	0.00	0.00	5.96	17.87	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	269.62	3.10	1.75	0.19	0.58	1.55	1.16	2.91	0.97
Fibroblast - Periodontal Ligament, donor2	11319-117D5	442.00	7.13	2.43	2.73	0.76	0.91	4.10	5.31	4.70
Fibroblast - Periodontal Ligament, donor3	11395-118C9	191.24	0.61	0.31	0.31	0.00	0.00	2.45	3.06	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	188.52	1.53	0.00	0.00	0.00	0.00	1.14	4.20	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	135.00	1.62	0.81	0.00	0.54	0.54	2.43	1.62	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	103.33	1.62	0.23	0.00	0.35	0.23	1.16	0.93	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	197.08	2.10	1.33	0.55	0.33	0.44	3.65	4.09	0.77
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	197.91	3.25	0.20	0.41	1.02	0.20	1.83	3.05	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	255.25	1.34	0.67	0.00	0.00	0.67	2.00	1.34	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	139.17	0.40	1.19	0.00	0.00	0.40	1.58	0.40	1.19
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	249.25	2.58	1.19	0.79	0.99	0.20	4.37	4.76	2.38
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	78.68	1.07	0.18	0.18	0.53	0.00	0.53	0.36	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	102.48	1.38	0.79	0.20	0.20	0.39	0.99	0.79	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	181.42	1.81	0.60	1.20	0.30	1.20	3.01	5.72	0.60
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	182.65	2.91	0.65	0.54	0.22	0.54	2.70	2.16	1.30
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	155.64	2.28	0.51	0.25	0.51	0.51	1.01	0.76	0.51
Fibroblast - skin normal, donor1	11553-120C5	78.59	1.80	0.49	0.00	0.16	0.00	1.15	0.49	0.33
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	187.07	2.01	0.80	1.20	0.20	0.20	2.21	3.61	0.40
Fibroblast - skin normal, donor2	11561-120D4	141.75	2.11	0.60	0.40	0.20	0.30	2.11	1.81	0.80
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	237.26	2.72	0.91	0.91	0.60	0.60	2.72	3.02	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	115.16	2.32	0.17	0.33	0.17	0.00	1.49	0.83	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	109.41	1.71	0.51	0.00	0.17	0.17	0.51	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	149.11	2.30	0.99	0.33	0.00	0.33	1.31	2.96	1.31
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	147.96	2.02	0.43	0.00	0.53	0.32	2.66	1.81	0.75
Fibroblast - skin walker warburg, donor1	11554-120C6	182.18	1.86	0.67	0.34	0.67	0.34	2.70	2.19	1.18
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	111.34	2.35	1.41	0.00	0.16	0.16	0.63	0.16	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	1263.11	44.32	0.00	0.00	22.16	0.00	44.32	44.32	44.32
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	108.07	3.49	0.87	0.00	1.74	1.74	1.74	0.87	0.87
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	59.46	1.21	0.52	0.17	0.17	0.00	0.52	1.73	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	79.37	1.04	0.26	0.78	0.78	0.00	1.30	0.78	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	81.00	2.30	0.51	0.26	0.00	0.00	0.77	1.28	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	493.78	20.67	3.06	2.30	3.83	0.77	22.20	21.44	2.30
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	549.38	22.97	5.74	1.91	1.91	3.19	22.97	29.99	5.74
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	1024.95	26.81	4.85	5.13	4.28	3.14	30.52	21.68	6.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	561.72	20.41	4.14	1.93	3.58	0.83	5.52	5.24	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	367.15	8.90	1.60	0.46	2.28	0.46	5.02	3.42	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	638.38	19.81	5.15	3.96	1.39	0.79	12.28	13.27	4.16
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	484.53	18.50	2.38	1.59	1.85	1.32	4.76	3.17	4.76
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	299.40	4.24	0.65	1.63	0.98	0.65	4.89	3.26	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	774.33	18.57	11.06	3.10	5.31	4.86	16.80	16.36	7.52
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	636.52	15.12	1.98	3.82	1.13	0.42	6.92	4.24	6.92
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	471.88	11.94	1.97	2.22	1.97	2.22	7.39	4.68	4.31
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	439.20	11.82	2.15	3.49	3.49	2.95	11.01	9.13	5.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	396.09	13.38	0.99	2.35	0.62	0.25	4.09	2.11	4.46
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	458.74	15.09	1.25	2.91	1.38	0.69	5.12	2.77	3.74
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	359.85	13.01	2.24	3.66	0.81	0.81	7.52	3.86	3.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	240.04	7.07	1.14	1.14	1.60	1.60	3.19	3.65	1.83
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	311.17	9.34	1.49	1.99	1.00	1.00	3.11	2.37	1.74
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	250.49	8.52	0.22	1.31	0.87	0.66	2.40	1.53	0.66
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	249.98	4.14	1.77	2.36	0.30	1.18	3.25	2.07	4.14
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	447.31	8.27	2.07	1.59	2.07	0.95	4.93	2.86	7.47
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	251.79	7.15	0.67	1.12	0.67	0.67	2.68	1.79	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	335.11	8.07	1.81	1.41	0.60	1.01	3.43	2.22	2.82
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	478.22	8.14	1.87	2.04	1.19	0.85	5.09	4.75	3.56
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	326.05	8.16	1.24	0.89	0.44	0.80	3.46	3.55	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	193.44	4.06	0.94	0.52	0.10	0.10	1.98	1.46	1.77
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	169.41	3.42	0.51	0.17	0.17	0.00	1.02	1.20	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	386.07	6.53	0.77	0.33	1.44	0.89	2.88	1.88	3.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	313.48	6.57	2.08	1.50	0.50	0.42	2.66	3.58	0.75
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	257.27	6.94	0.20	1.02	0.61	0.20	3.27	2.04	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	248.39	4.33	1.03	0.83	0.41	1.03	2.48	1.24	1.44
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	355.68	4.61	0.92	0.46	0.92	0.92	2.65	1.04	2.42
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	271.16	5.00	1.00	0.50	1.00	0.83	3.00	2.84	2.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	189.57	3.53	1.10	0.00	0.66	0.44	2.65	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	314.86	5.29	0.86	0.98	0.61	1.23	3.20	0.86	3.57
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	281.72	4.38	0.65	1.30	1.30	0.49	3.73	1.78	1.78
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	184.41	4.17	0.64	0.32	0.64	0.32	0.96	0.64	1.60
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	273.18	3.51	0.57	0.47	1.23	0.95	2.65	1.14	3.13
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	206.26	4.11	0.16	0.95	0.79	0.63	1.90	1.74	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	219.55	6.39	1.22	0.91	0.61	0.30	1.82	0.30	2.13
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	281.84	3.24	1.05	0.63	0.63	0.84	3.14	1.57	1.99
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	167.52	3.51	0.44	0.44	0.66	0.22	1.54	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	176.18	4.77	1.68	0.28	1.40	0.84	2.24	0.56	1.40
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	204.52	0.83	0.65	0.65	0.56	0.46	2.22	1.94	2.87
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	173.01	1.60	0.27	1.07	0.53	0.00	3.21	1.60	2.14
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	195.85	1.68	1.38	0.92	0.77	0.46	3.37	2.75	1.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	243.14	2.72	0.39	0.13	0.13	1.04	2.98	1.55	2.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	162.10	2.98	0.81	0.27	0.00	0.27	1.63	2.44	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	181.59	2.95	0.74	0.00	0.55	0.00	2.58	1.11	2.95
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	157.03	2.63	0.44	0.44	0.66	0.22	2.41	1.32	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	308.43	5.95	0.00	0.00	0.00	0.00	0.99	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	180.98	2.64	0.13	0.79	0.53	0.92	3.69	1.45	2.24
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	144.05	1.21	0.40	0.00	1.01	0.81	2.02	0.81	1.01
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	159.61	2.29	0.25	0.00	0.00	0.25	1.52	0.76	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	713.83	15.33	3.38	2.79	1.00	0.60	13.34	12.34	3.58
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	596.12	19.11	1.69	3.85	1.69	1.69	10.01	4.93	3.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	931.26	30.69	1.84	4.91	0.61	1.02	15.96	5.73	6.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	458.13	17.21	2.19	3.44	0.94	0.63	15.33	16.90	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	413.10	10.74	1.41	2.83	1.70	0.57	14.13	12.71	1.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	479.65	27.21	3.23	4.61	1.38	3.23	7.38	10.61	6.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	351.42	7.42	2.47	2.47	0.00	7.42	17.32	19.80	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	560.10	18.95	3.48	7.35	3.09	4.25	25.92	16.63	5.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	442.83	16.04	3.21	1.60	1.60	3.21	8.02	22.46	4.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	365.15	15.65	3.48	3.48	3.48	0.00	8.69	12.17	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	436.79	17.58	3.91	3.58	1.95	0.98	20.18	15.95	3.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	493.34	15.24	4.94	5.35	2.47	1.65	17.30	18.94	5.35
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	376.55	26.66	29.99	0.00	16.66	10.00	23.33	10.00	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	426.74	15.66	3.08	3.64	2.24	2.52	12.02	11.75	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	452.35	14.05	3.27	2.29	3.60	0.98	14.71	15.03	3.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	435.36	15.94	10.07	1.68	18.45	2.52	8.39	6.71	12.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	463.43	14.31	1.59	2.86	2.86	0.32	7.32	10.81	3.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	488.09	13.93	3.40	1.36	3.06	1.36	11.55	12.91	5.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	290.25	12.53	4.18	2.09	0.00	0.00	10.44	2.09	4.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	549.22	30.35	5.15	2.86	2.29	2.29	10.31	5.15	4.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	380.63	15.39	3.85	2.37	3.55	1.48	4.14	5.03	3.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	262.59	11.86	3.39	0.00	5.08	5.08	5.08	3.39	11.86
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	556.28	13.67	7.04	0.83	2.07	2.90	16.15	12.43	9.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	494.55	11.97	3.22	2.07	2.07	1.84	12.89	11.05	3.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	231.81	0.00	0.00	0.00	0.00	0.00	10.54	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	366.34	11.92	3.46	1.15	0.77	1.54	5.38	4.61	4.61
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	291.42	10.43	1.63	0.65	1.63	0.00	7.50	5.54	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	208.01	10.70	0.00	0.67	2.68	0.00	4.01	4.68	1.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	366.39	13.10	4.24	0.39	3.08	1.16	5.01	2.70	5.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	442.30	14.04	4.11	3.42	2.74	1.03	7.87	7.19	4.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	223.63	12.42	0.00	0.00	7.45	2.48	4.97	4.97	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	272.26	11.80	0.94	0.94	1.42	0.47	4.72	2.36	3.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	305.37	12.67	3.02	0.00	4.22	2.41	6.03	2.41	4.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	305.71	10.17	1.02	0.51	2.03	0.51	2.03	2.54	3.56
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	389.67	12.76	4.39	1.20	2.79	0.00	5.58	4.79	5.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	314.76	11.84	0.49	0.49	2.47	1.97	3.45	1.97	2.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	293.93	15.35	5.90	2.36	5.90	1.18	3.54	3.54	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	315.64	8.75	2.33	0.00	1.17	0.58	4.08	0.58	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	219.00	7.02	0.88	0.88	1.76	0.00	1.32	0.44	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	257.70	11.02	3.39	2.54	1.70	0.00	3.39	2.54	4.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	246.53	3.58	3.58	1.19	4.18	0.60	1.79	2.98	5.97
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	240.68	5.34	2.91	1.46	1.46	0.49	5.34	4.37	1.94
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	84.46	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	143.46	2.91	1.66	0.42	2.49	2.08	2.08	0.83	3.33
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	89.96	3.37	0.00	0.00	0.00	0.00	3.37	1.12	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	53.28	1.27	0.63	0.32	0.00	0.00	0.32	0.00	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	25.90	0.84	0.00	0.00	0.00	0.00	0.00	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	195.07	4.18	0.93	0.35	0.58	0.81	5.11	6.50	2.20
Hep-2 cells mock treated, biol_rep2	11899-125E9	182.98	4.39	0.51	0.84	1.18	1.69	5.23	7.09	1.52
Hep-2 cells mock treated, biol_rep3	11900-125F1	190.65	2.28	0.68	0.91	0.91	1.14	4.55	7.05	2.05
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	195.01	3.94	1.20	1.09	0.66	0.44	4.81	6.34	2.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	185.90	4.30	0.43	1.50	0.21	1.07	4.94	9.03	1.72
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	188.59	3.66	0.43	0.86	1.08	1.08	6.67	8.40	2.58
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	173.73	3.61	1.12	0.75	1.12	1.25	3.11	7.10	2.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	168.29	4.97	0.34	1.54	0.51	0.34	2.40	6.18	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	149.29	5.77	0.64	0.96	0.64	1.60	5.13	6.73	1.60
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	155.02	3.36	1.68	1.12	0.56	0.00	0.00	3.36	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	151.48	4.76	0.00	2.16	0.00	0.43	1.30	1.73	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	155.98	2.64	2.64	0.00	2.64	2.64	5.29	2.64	7.93
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	146.73	1.76	0.35	0.35	0.35	0.35	1.41	1.76	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	108.98	0.00	0.73	0.00	0.00	0.73	0.73	0.73	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	214.35	1.75	2.45	0.87	1.22	0.87	5.59	3.50	4.55
Hepatocyte, donor1	11523-119I2	124.69	10.90	1.21	0.00	2.42	1.21	2.42	0.00	2.42
Hepatocyte, donor2	11603-120I1	136.82	7.54	2.15	0.00	2.15	1.08	1.08	1.08	2.15
Hepatocyte, donor3	11684-122I1	143.57	4.29	2.45	0.00	0.00	0.00	0.00	1.23	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	321.12	5.22	0.65	0.65	2.61	0.00	5.22	4.57	6.53
Intestinal epithelial cells (polarized), donor1	11246-116E4	212.88	5.24	0.52	0.70	0.70	1.05	1.75	1.75	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	150.24	3.57	1.10	0.41	0.69	0.41	1.78	2.33	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	235.61	0.00	0.00	0.00	0.00	0.00	6.37	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	173.56	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	177.20	6.92	0.00	2.77	0.00	1.38	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	127.64	12.51	0.00	2.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	284.84	0.00	0.00	0.00	0.00	0.00	0.00	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	151.21	5.13	0.00	0.00	0.00	0.00	0.00	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	137.12	9.14	0.00	0.00	0.00	0.00	4.57	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	225.78	9.75	3.25	0.00	0.00	0.00	4.87	3.25	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	183.40	8.34	0.00	0.00	0.00	0.00	5.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	108.92	7.26	0.00	0.00	0.00	0.00	0.00	0.00	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	157.49	6.62	0.00	0.00	0.00	0.00	5.29	3.97	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	190.69	6.65	1.11	0.00	0.00	0.00	3.33	2.22	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	146.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	228.01	6.93	3.15	1.89	0.00	0.63	3.78	1.89	4.41
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	196.42	4.64	0.00	1.55	0.00	1.55	1.55	4.64	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	190.25	29.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	222.24	7.75	0.65	0.00	0.00	0.00	3.23	1.29	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	181.92	6.44	0.00	0.00	0.00	0.00	8.05	1.61	3.22
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	203.12	0.00	0.00	0.00	0.00	0.00	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	213.50	10.59	0.00	1.63	0.00	0.00	2.44	1.63	1.63
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	159.11	8.82	0.42	0.00	0.00	0.00	3.36	1.68	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	255.57	6.43	4.02	1.61	0.00	0.00	5.63	2.41	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	168.04	14.77	2.77	0.00	0.00	0.92	5.54	2.77	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	227.99	6.14	0.47	0.47	0.00	0.94	2.36	3.78	1.89
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	152.37	9.98	1.81	2.72	0.91	0.00	1.81	1.81	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	132.68	29.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	251.81	9.69	1.08	0.00	0.00	0.00	3.23	1.08	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	184.22	7.62	0.00	1.27	0.00	0.00	7.62	2.54	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	213.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	216.81	4.46	1.28	0.00	0.64	1.28	3.19	3.19	3.83
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	158.57	5.47	1.82	0.00	0.00	0.00	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	126.43	15.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	217.79	12.14	0.71	0.71	0.71	0.71	1.43	0.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	162.60	13.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	245.69	5.25	1.23	1.23	0.31	0.00	2.78	1.23	2.47
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	154.53	3.51	0.00	0.00	0.00	0.00	8.78	3.51	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	119.44	9.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	196.10	1.39	0.00	1.39	0.00	0.00	2.09	1.39	1.39
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	181.47	8.85	0.00	0.00	0.00	0.00	6.64	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	165.34	3.24	0.00	0.00	3.24	0.00	6.48	3.24	6.48
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	196.18	2.62	0.00	1.74	0.00	0.00	2.62	1.74	1.74
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	103.49	4.50	4.50	0.00	0.00	0.00	2.25	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	149.84	10.45	0.00	0.00	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	204.82	3.20	0.00	2.13	0.00	0.00	1.07	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	149.63	4.16	0.00	1.39	0.00	1.39	1.39	2.77	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	153.88	8.55	2.85	0.00	0.00	0.00	0.00	5.70	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	172.12	1.84	0.00	0.00	0.92	0.00	2.76	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	121.01	0.00	0.00	0.00	0.00	0.00	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	142.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	115.25	1.06	0.00	0.00	0.00	0.00	1.06	0.00	3.17
Keratinocyte - epidermal, donor1	11272-116H3	106.32	2.86	0.24	0.98	0.08	0.00	0.65	1.88	0.08
Keratinocyte - epidermal, donor2	11349-117G8	65.59	1.17	0.59	0.59	0.00	0.00	0.59	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	262.58	4.64	1.04	1.14	1.04	0.95	2.65	3.31	2.18
Keratinocyte - oral, donor1	11251-116E9	212.96	2.61	0.91	1.02	0.11	0.23	2.16	1.59	1.25
Keratocytes, donor1	11527-119I6	275.41	1.03	1.03	0.34	0.34	0.00	1.03	0.34	0.34
Keratocytes, donor2	11607-120I5	191.00	2.34	2.34	0.00	0.00	0.00	3.52	1.17	3.52
Keratocytes, donor3	11688-122I5	161.04	1.19	0.59	0.20	0.79	0.20	0.00	0.20	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	211.00	6.59	0.00	2.20	0.00	0.00	6.59	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	187.70	5.39	2.16	0.00	1.08	1.08	1.08	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	189.03	4.84	0.92	0.58	0.00	0.12	1.27	1.04	0.46
Lens Epithelial Cells, donor3	11690-122I7	102.73	2.22	0.00	0.30	0.10	0.00	0.71	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	140.28	1.19	0.47	0.24	0.36	0.12	0.95	1.66	0.83
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	113.03	1.12	0.28	0.28	1.12	0.84	1.95	1.40	1.95
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	139.78	1.42	1.73	0.16	1.26	0.79	2.05	2.05	1.57
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	115.07	1.08	0.54	0.00	1.08	0.00	0.54	2.15	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	104.32	2.52	1.58	0.32	0.95	0.63	0.63	2.21	1.89
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	125.06	1.51	1.29	0.22	0.32	0.54	1.40	1.40	1.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	108.75	1.23	1.64	0.00	0.00	0.82	0.82	1.23	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	87.22	2.02	0.76	0.25	0.25	0.76	1.26	1.77	0.76
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	138.50	2.11	1.27	0.28	0.56	0.99	1.13	0.28	0.84
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	87.41	0.79	0.00	0.00	0.00	0.00	1.19	1.19	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	112.26	1.36	0.39	0.00	0.00	0.58	1.74	1.55	0.78
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	86.65	0.37	0.56	0.00	0.19	0.19	1.11	0.93	0.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	113.24	1.74	1.05	0.00	1.39	0.35	2.09	2.09	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	131.19	1.43	0.48	0.48	1.19	0.72	0.95	1.91	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	121.14	1.51	1.10	0.41	0.55	0.69	1.92	1.51	1.24
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	105.94	0.31	0.31	0.00	0.62	0.92	0.62	2.46	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	80.74	1.56	0.62	0.00	0.62	1.25	0.62	1.56	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	149.50	1.65	1.10	0.73	0.37	0.18	0.91	2.01	1.28
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	120.13	0.66	2.30	0.33	0.66	0.33	2.30	1.65	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	93.43	0.88	0.59	0.00	0.59	0.00	0.88	1.46	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	137.41	2.49	1.74	0.25	0.25	0.25	1.00	0.75	1.24
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	114.94	1.94	0.48	0.00	1.45	0.48	3.39	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	107.18	2.69	0.27	0.00	0.54	0.81	0.81	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	155.62	1.97	1.21	0.45	0.45	1.36	1.97	2.57	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	96.94	1.56	0.00	0.00	1.04	0.00	0.00	0.52	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	109.72	1.47	2.09	0.00	1.26	0.42	1.47	3.14	1.68
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	135.33	1.35	1.35	0.60	0.75	1.05	1.95	1.50	1.50
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	96.30	0.69	0.69	0.00	0.00	0.00	0.69	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	97.27	2.07	0.56	0.19	0.19	0.19	1.69	0.94	0.94
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	127.55	1.59	0.53	0.32	0.74	0.95	1.80	1.80	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	84.32	0.00	1.45	0.48	0.48	0.48	1.94	1.45	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	78.07	1.65	0.66	0.00	1.65	0.00	0.99	0.66	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	134.55	0.74	1.49	0.00	1.36	0.50	1.86	1.24	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	143.64	1.85	0.37	0.00	0.37	0.37	1.11	1.85	1.11
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	86.23	2.96	0.00	0.00	0.25	0.74	0.49	1.24	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	127.59	1.24	1.79	0.14	0.69	0.82	1.24	1.92	1.10
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	106.14	0.64	0.32	0.64	0.00	0.96	0.32	2.25	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	100.73	0.61	1.22	0.00	0.61	0.61	0.30	2.74	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	145.14	1.68	1.54	0.00	0.84	0.56	1.96	2.10	0.84
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	102.76	0.36	0.36	0.36	0.36	0.00	0.71	1.42	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	71.75	1.45	0.97	0.00	0.48	0.00	1.45	1.94	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	115.31	0.31	1.24	0.47	0.16	0.62	1.56	1.09	0.93
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	102.78	1.79	0.72	0.00	0.00	0.36	1.43	2.51	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	101.92	0.33	0.00	0.00	0.00	0.33	0.65	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	109.94	0.71	0.94	0.00	0.24	0.47	1.18	2.12	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	131.18	2.10	0.62	0.25	0.12	0.00	1.24	2.10	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	77.35	0.77	0.77	0.00	0.00	0.26	1.54	2.05	1.02
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	150.67	1.19	2.69	0.30	0.90	0.30	2.69	2.39	1.79
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	83.84	0.00	2.27	0.00	0.00	0.00	0.00	2.27	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	118.91	2.30	0.77	1.53	2.30	0.77	5.37	5.37	1.53
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	92.78	0.74	0.74	0.74	0.00	0.00	2.97	2.23	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	97.32	0.42	1.27	0.42	0.00	0.00	3.39	3.39	1.69
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	111.83	2.11	0.00	0.00	0.00	0.00	2.11	2.81	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	85.92	0.00	0.93	0.93	1.87	0.00	2.80	2.80	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	103.57	3.09	1.55	0.00	1.03	0.52	3.09	4.64	2.06
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	85.64	0.00	2.38	1.19	0.00	1.19	0.00	0.00	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	97.26	1.58	0.68	0.00	0.45	0.23	1.58	2.71	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	130.00	2.04	0.58	0.29	1.16	0.58	4.07	4.36	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	154.41	1.80	1.35	0.00	1.35	0.45	2.25	4.95	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	133.59	2.30	1.22	0.14	0.14	0.14	2.03	3.39	0.95
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	118.11	1.54	2.57	0.51	1.54	0.51	2.05	4.62	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	136.20	1.41	0.71	0.35	0.71	0.71	2.82	5.29	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	137.26	0.67	0.67	0.00	0.67	0.00	5.33	4.66	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	104.42	1.53	0.51	0.51	2.55	2.04	3.06	4.08	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	138.21	1.60	0.27	0.27	1.07	0.00	1.87	3.47	2.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	165.33	1.51	1.70	0.57	1.13	0.76	4.16	3.78	2.65
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	89.58	0.61	0.61	0.00	1.23	0.00	1.84	3.68	1.23
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	143.51	0.82	0.82	1.63	1.63	0.82	3.26	7.34	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	162.85	3.96	2.71	0.62	2.08	1.25	4.16	3.33	2.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	136.49	1.96	3.92	0.84	1.40	1.40	3.36	1.68	2.24
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	124.67	2.06	0.00	0.00	0.00	0.00	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	156.76	3.48	3.48	0.87	2.32	2.03	2.90	6.97	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	125.55	2.09	1.49	0.00	0.90	0.60	2.09	3.29	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	131.12	1.66	1.11	1.66	0.55	0.00	2.21	5.53	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	156.95	3.18	2.12	0.00	2.47	0.35	2.12	2.12	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	110.63	3.32	1.48	0.00	1.11	0.37	2.21	5.16	3.32
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	107.07	1.15	0.00	1.15	0.00	1.15	2.30	6.91	5.76
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	130.48	1.54	2.69	0.38	1.15	0.77	2.30	5.37	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	116.06	1.13	2.26	0.00	0.57	2.26	1.13	2.83	3.40
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	116.51	0.00	0.82	0.00	0.82	0.00	5.74	4.92	4.92
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	118.39	0.90	1.36	0.00	1.36	0.90	4.52	4.52	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	113.47	3.59	0.72	0.00	0.72	2.87	0.72	2.87	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	148.63	1.49	0.75	0.75	0.75	0.75	8.22	5.98	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	156.81	1.49	2.97	0.74	1.86	0.74	4.09	1.11	3.34
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	130.95	3.45	0.86	0.43	0.86	0.43	2.58	4.31	2.58
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	151.56	2.57	0.86	0.00	0.00	0.00	0.00	4.28	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	178.92	0.67	3.33	1.00	1.67	0.33	5.00	5.00	4.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	125.49	3.02	1.81	0.00	1.81	1.21	1.81	1.81	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	120.16	1.42	0.71	0.00	0.00	0.00	2.84	2.84	2.84
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	140.92	1.03	2.75	0.34	0.69	0.00	1.72	5.16	3.78
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	88.56	0.54	4.83	0.54	1.61	0.54	1.61	2.68	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	112.45	4.04	0.00	0.00	0.00	0.00	2.02	2.69	3.37
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	157.05	1.85	2.59	0.00	1.48	1.11	6.30	3.33	3.70
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	122.11	1.16	0.00	0.00	0.00	0.00	3.49	2.33	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	104.72	3.17	0.00	0.00	1.06	0.00	1.06	1.06	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	169.66	1.20	0.80	0.40	0.00	0.40	4.80	3.20	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	74.14	2.18	0.73	0.00	1.45	0.00	2.18	2.18	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	92.75	0.77	0.77	0.00	0.00	0.77	1.53	6.13	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	112.96	0.49	2.47	0.49	0.99	0.99	4.93	3.95	1.48
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	92.21	1.88	0.00	0.00	0.94	0.00	1.88	2.82	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	105.59	2.01	0.50	0.00	1.51	0.50	3.02	3.02	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	127.08	2.25	0.45	0.45	0.90	0.00	2.70	4.06	2.70
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	75.73	1.72	0.00	0.00	0.00	1.72	3.44	3.44	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	116.68	2.67	1.78	0.45	1.34	0.00	1.34	3.12	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	135.29	1.96	0.39	0.39	0.39	0.39	3.52	3.91	3.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	87.74	1.32	1.98	0.00	0.66	0.00	2.64	3.96	2.64
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	118.32	0.52	1.04	0.52	1.56	1.04	2.59	1.04	2.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	167.59	2.19	3.06	0.00	1.31	0.00	3.50	3.06	6.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	86.66	2.24	0.00	0.56	0.56	0.00	2.80	3.35	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	102.90	0.88	0.88	0.00	0.88	0.00	2.21	2.65	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	124.97	0.77	1.93	0.39	1.54	0.39	1.93	6.56	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	105.83	0.51	3.04	0.51	0.00	0.51	2.53	3.54	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	118.23	2.88	1.44	0.48	1.44	0.96	5.29	1.92	1.92
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	131.59	2.39	1.19	0.40	1.19	1.19	5.17	2.78	1.59
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	97.22	0.61	2.43	1.22	4.25	0.61	1.22	3.04	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	98.22	0.00	0.69	0.00	1.38	0.00	4.15	1.38	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	118.18	1.52	2.28	0.00	0.38	0.76	2.28	3.42	1.90
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	91.92	0.52	2.07	0.52	0.00	0.52	2.58	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	93.72	3.02	0.60	0.00	0.60	0.00	2.42	4.23	1.21
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	168.59	2.22	2.22	0.63	0.63	0.63	4.44	3.80	2.85
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	92.76	0.53	1.07	0.53	1.07	0.00	3.73	2.67	1.07
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	85.05	1.72	0.00	0.57	0.00	0.00	1.15	3.45	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	145.01	3.09	3.09	1.03	0.51	1.03	2.06	2.06	1.54
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	111.05	0.71	2.83	0.71	0.71	0.00	0.71	5.66	0.71
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	107.25	0.57	0.57	1.13	0.00	0.00	0.57	5.11	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	164.75	3.33	1.25	0.00	3.74	0.83	2.08	2.91	1.66
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	108.84	2.35	0.00	0.00	0.00	0.78	0.78	6.26	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	112.32	0.84	0.00	0.00	0.84	0.84	1.25	2.51	1.67
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	138.93	1.86	2.32	0.00	1.39	0.93	1.86	2.32	2.32
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	107.72	0.00	3.35	0.67	0.67	0.00	2.68	1.34	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	124.57	1.60	2.14	0.00	0.00	1.60	3.21	2.67	3.74
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	177.80	3.64	1.21	0.40	1.21	0.40	6.06	5.25	4.85
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	110.13	0.92	2.75	0.92	0.00	0.92	0.92	4.59	5.51
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	112.92	0.89	1.78	0.00	0.00	0.89	2.67	9.78	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	132.78	1.71	0.57	0.57	0.00	0.57	3.99	5.13	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	111.97	2.30	0.77	1.53	1.53	0.00	3.07	3.83	2.30
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	132.42	3.28	0.55	0.55	1.09	0.00	4.92	4.38	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	151.01	1.34	2.67	0.00	0.89	1.34	2.67	4.90	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	144.79	1.82	0.52	0.52	0.00	0.00	2.34	4.16	1.04
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	134.61	1.33	1.33	0.00	0.00	1.33	5.97	9.95	1.33
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	101.85	4.16	2.08	0.00	4.16	0.00	10.39	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	98.92	0.91	0.23	0.00	0.00	0.46	0.23	0.46	0.23
Macrophage - monocyte derived, donor2	11313-117C8	48.08	1.47	0.37	0.00	0.18	0.00	0.55	0.55	0.18
Macrophage - monocyte derived, donor3	11389-118C3	83.11	1.70	0.26	0.39	0.66	0.13	0.92	0.66	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	33.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	73.20	1.74	0.00	0.63	0.00	0.32	1.27	0.79	0.48
Mallassez-derived cells, donor3	11930-125I4	130.79	2.78	0.42	0.83	0.42	0.83	3.20	3.61	1.11
Mammary Epithelial Cell, donor1	11273-116H4	237.15	2.79	1.49	1.30	0.70	0.30	1.89	2.69	0.50
Mammary Epithelial Cell, donor2	11350-117G9	206.45	1.45	1.45	0.29	0.87	0.58	3.76	1.74	0.58
Mammary Epithelial Cell, donor3	11422-118F9	135.94	1.75	1.25	0.50	0.50	0.25	0.75	2.24	1.00
Mast cell - stimulated, donor1	11487-119E2	377.61	4.75	0.00	0.00	0.00	0.68	5.42	5.42	1.36
Mast cell, donor1	11563-120D6	252.08	1.51	0.65	0.54	0.76	0.54	2.49	2.27	0.32
Mast cell, donor2	11565-120D8	439.82	4.46	0.59	0.30	0.00	0.59	1.49	2.97	0.59
Mast cell, donor3	11566-120D9	564.61	4.28	0.23	0.45	0.00	0.45	4.95	2.48	0.68
Mast cell, donor4	11567-120E1	417.69	4.08	0.35	0.35	0.18	0.00	3.55	3.55	0.89
Mast cell, expanded and stimulated, donor5	11940-126A5	249.18	2.44	1.11	0.33	0.55	0.55	1.22	1.11	1.66
Mast cell, expanded and stimulated, donor8	11942-126A7	203.12	1.17	0.00	0.00	0.58	1.17	2.92	6.42	1.17
Mast cell, expanded, donor5	11939-126A4	209.48	1.72	1.15	0.00	0.23	0.34	2.06	2.52	0.80
Mast cell, expanded, donor8	11941-126A6	297.58	2.18	0.50	0.17	0.33	2.51	3.35	4.85	1.34
Melanocyte - dark, donor1	11502-119F8	190.94	1.39	0.80	0.40	0.10	0.10	2.69	1.79	0.30
Melanocyte - dark, donor2	11582-120F7	138.78	0.69	0.00	0.35	0.35	1.38	3.46	1.38	0.69
Melanocyte - dark, donor3	11663-122F7	210.15	1.09	0.51	0.65	0.43	0.36	1.81	2.54	0.36
Melanocyte - light, donor1	11274-116H5	78.04	0.24	0.24	0.24	0.24	0.00	0.47	0.94	0.94
Melanocyte - light, donor2	11351-117H1	47.77	0.00	0.68	0.68	0.00	0.00	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	83.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	243.24	2.29	1.15	1.04	0.62	0.31	2.08	1.35	1.67
Melanocyte, donor2 (MC+2)	12739-135I3	136.62	1.34	0.54	0.54	0.54	1.08	1.88	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	160.18	0.80	0.54	0.54	0.27	0.54	0.80	1.87	0.27
Meningeal Cells, donor1	11493-119E8	290.55	1.86	0.00	0.74	0.12	0.12	2.36	4.47	0.62
Meningeal Cells, donor2	11573-120E7	232.40	2.64	0.00	0.88	0.00	0.00	3.52	3.96	0.44
Meningeal Cells, donor3	11654-122E7	334.48	3.99	1.55	0.90	0.90	0.33	3.75	6.60	1.63
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	240.96	3.42	0.57	1.14	0.57	0.57	0.86	1.71	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.13	0.81	0.40	0.20	0.00	0.00	0.70	0.20	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	63.08	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	163.52	2.62	0.00	0.00	1.31	0.00	2.62	0.00	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	188.73	2.15	0.00	0.72	0.72	0.72	3.59	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	81.95	1.91	0.85	0.42	0.42	0.21	1.27	0.85	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	96.51	2.01	1.51	0.50	0.00	0.00	1.01	1.51	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	166.79	2.20	1.32	1.32	0.66	0.00	1.54	2.86	2.20
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	260.82	3.65	0.73	1.46	0.73	0.00	4.38	3.65	2.92
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	170.64	3.27	0.82	0.61	0.61	0.82	1.64	3.89	1.02
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	85.32	1.80	0.28	0.42	0.00	0.42	0.55	0.28	0.55
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	73.97	0.37	0.37	0.00	0.00	0.00	0.00	1.12	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	108.42	0.66	1.05	0.13	0.26	0.39	0.26	0.13	0.79
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	67.66	0.00	1.19	0.00	0.30	0.00	0.00	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	84.08	0.00	2.34	0.00	0.00	0.00	0.00	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	209.41	5.12	1.28	0.00	1.28	0.64	3.20	3.20	1.28
Mesenchymal stem cells - adipose, donor0	11217-116B2	254.49	1.77	1.77	0.71	0.35	0.35	2.13	1.06	1.42
Mesenchymal stem cells - hepatic, donor0	11218-116B3	106.95	0.94	0.00	0.00	0.31	0.31	0.31	0.31	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	309.87	2.18	0.73	3.63	0.00	0.73	3.63	3.63	3.63
Mesothelial Cells, donor1	11247-116E5	47.47	2.12	0.27	0.00	0.00	0.00	0.27	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	37.53	0.50	1.50	0.00	0.00	0.00	1.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	70.67	2.24	0.79	0.51	0.58	0.65	0.87	1.45	1.52
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	103.97	8.10	0.00	0.00	0.00	0.00	4.05	2.70	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	93.83	1.97	0.00	0.49	0.25	0.25	0.25	0.25	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	53.59	2.36	0.29	0.00	0.59	0.00	0.00	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	56.10	0.93	0.00	0.31	0.31	0.00	0.62	0.31	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	46.26	2.07	0.83	0.00	0.21	0.62	0.41	0.41	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	48.64	6.95	0.00	0.00	0.00	0.00	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	66.82	2.25	0.50	0.25	0.00	0.00	0.00	0.00	0.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	58.18	3.72	1.40	0.00	0.93	0.47	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	68.28	1.83	0.81	0.00	0.00	0.00	1.02	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	42.37	1.98	0.40	0.00	0.79	1.58	0.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	8.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	53.10	2.65	0.88	0.88	0.00	0.00	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	50.15	1.90	1.14	0.00	0.76	0.00	0.38	0.38	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	44.74	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	61.97	0.85	1.91	0.00	0.42	0.42	1.06	0.85	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	26.70	3.68	0.92	0.00	0.00	0.00	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	64.68	2.38	1.19	0.00	0.30	0.30	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	38.56	0.00	0.00	0.00	0.00	0.00	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	58.71	2.01	0.75	0.00	0.00	0.00	1.00	0.25	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	38.50	1.43	0.24	0.00	0.48	0.24	0.71	0.71	0.95
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	37.60	2.76	0.00	0.00	0.00	0.55	0.55	0.55	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	54.11	1.84	0.46	0.23	0.00	0.00	0.00	0.23	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	34.29	2.10	0.00	0.42	0.42	0.00	0.21	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	54.01	2.45	0.41	0.41	0.00	0.00	0.00	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	47.41	0.86	0.00	0.21	0.00	0.21	0.21	0.00	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	37.12	2.00	0.00	0.22	0.22	0.22	0.67	1.11	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	10.32	0.00	0.00	0.00	0.00	10.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	49.28	2.63	0.22	0.44	0.22	0.00	0.66	0.66	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	32.45	1.01	0.00	0.51	0.51	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	26.51	1.66	0.00	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	61.70	3.81	0.27	0.54	0.00	0.27	0.27	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	34.70	1.18	0.00	0.29	0.29	0.00	0.59	0.88	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	37.07	3.27	0.00	0.00	0.00	0.00	1.09	2.18	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	47.57	1.92	0.00	0.00	0.00	0.00	0.48	2.40	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	31.62	1.60	0.40	0.40	0.40	0.00	0.40	0.80	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	79.53	0.00	0.00	0.00	0.00	0.00	0.00	1.37	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	50.06	3.50	0.00	0.50	1.00	0.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	55.04	4.08	0.00	0.00	0.00	0.00	0.00	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	54.30	1.75	0.00	0.44	0.00	0.88	2.19	1.75	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	37.52	7.73	0.00	0.00	1.10	0.00	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	63.40	1.92	0.00	0.00	0.64	0.00	0.64	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	70.16	1.98	0.50	0.50	0.50	0.50	0.25	0.74	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	41.75	3.48	0.00	0.00	0.00	0.00	0.70	2.09	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	68.51	8.84	0.00	0.00	0.00	0.00	2.21	2.21	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	67.01	1.71	1.03	0.68	0.00	0.34	0.34	0.00	1.03
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	49.45	1.75	0.44	0.00	0.00	0.00	1.75	3.06	0.44
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	104.75	2.49	0.36	0.36	0.00	0.00	0.36	0.36	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	64.81	1.12	0.00	0.00	0.56	0.00	1.12	1.40	0.56
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	29.93	0.83	0.00	0.00	0.00	0.42	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	59.44	1.75	0.00	0.58	0.00	0.00	0.00	0.58	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	60.03	2.41	0.30	0.60	0.00	0.90	0.90	0.90	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	48.42	0.83	0.00	0.83	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	72.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	55.41	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	46.67	3.41	0.00	0.00	0.00	0.00	1.14	1.14	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	81.39	2.21	0.00	0.14	0.00	0.14	0.55	0.41	0.41
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	66.86	1.30	0.26	0.00	0.00	0.00	0.00	1.30	1.04
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	56.62	1.72	0.43	0.43	0.43	0.86	0.00	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	47.64	0.00	0.00	0.00	0.00	0.00	0.64	1.27	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	59.78	1.33	0.00	0.00	0.53	0.27	1.07	0.27	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	48.79	1.80	0.00	0.60	0.00	0.00	1.20	0.30	0.30
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	66.53	0.99	0.14	0.00	0.14	0.00	0.42	0.14	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	63.70	0.96	0.32	0.00	0.64	0.00	0.64	0.32	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	73.86	1.99	0.22	0.22	0.44	0.00	0.66	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	48.92	2.65	0.00	0.00	0.00	0.00	0.38	0.38	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	69.32	1.42	0.00	0.00	0.28	0.00	0.00	1.14	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	55.06	2.21	0.98	0.25	0.00	0.49	0.74	0.74	0.49
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	58.65	1.96	0.00	0.00	0.00	0.00	1.30	1.96	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	64.69	0.88	0.00	0.29	0.00	0.29	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	60.26	1.15	0.00	0.00	0.58	0.58	0.29	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	86.96	1.65	0.41	0.41	0.00	0.00	1.65	0.82	0.41
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	56.58	1.19	0.30	0.00	0.30	0.00	1.19	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	33.86	1.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	89.04	1.97	1.97	0.66	0.33	0.66	0.66	0.00	0.99
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	54.70	0.00	1.05	0.00	1.05	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	54.96	0.59	0.59	0.00	0.00	0.20	0.00	0.20	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	56.81	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	89.38	1.50	0.38	0.38	0.38	0.00	0.38	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	55.40	1.86	0.27	0.00	0.53	0.27	0.00	0.27	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	78.27	0.90	0.57	0.11	0.11	0.00	0.11	0.23	0.34
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	53.78	0.00	1.47	0.00	0.00	0.00	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	80.61	0.73	0.73	0.00	0.73	0.37	0.73	0.73	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	63.78	1.56	3.11	0.00	1.56	0.00	0.00	1.56	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	87.11	1.60	0.53	0.00	0.00	0.00	0.53	1.07	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	27.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	69.69	1.01	0.00	0.00	1.01	0.00	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	67.04	2.11	0.84	0.00	0.00	0.00	0.00	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	43.58	8.17	0.00	0.00	0.00	0.00	0.00	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	41.33	1.91	0.00	0.00	0.00	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	61.55	2.43	0.00	0.00	0.00	0.00	0.00	0.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	55.89	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	62.81	0.00	0.00	0.00	0.00	0.00	11.42	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	55.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	42.77	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	92.85	0.65	0.65	0.65	0.00	0.00	0.65	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	122.81	2.09	0.52	1.05	1.05	0.00	3.66	1.57	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	42.72	0.67	0.00	0.00	0.00	0.00	0.67	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.39	1.25	0.00	0.00	0.00	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	288.25	3.04	0.38	0.57	0.57	0.38	5.51	4.56	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	304.81	6.38	1.60	0.00	1.60	0.00	0.00	3.19	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	27.20	0.68	0.00	0.00	0.00	0.00	0.00	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	501.68	5.51	0.00	1.84	3.68	0.00	1.84	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	33.06	0.84	0.00	0.00	0.00	0.42	0.00	0.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	71.82	0.93	0.23	0.23	0.00	0.46	2.32	1.16	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	38.37	1.08	0.27	0.00	0.00	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	115.21	0.63	0.42	0.00	0.42	0.21	2.10	0.84	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	723.76	44.54	0.00	0.00	11.13	0.00	22.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	37.72	0.00	0.00	0.50	0.50	0.50	0.00	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	113.68	0.54	0.54	0.00	0.54	0.54	0.81	0.54	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	24.94	0.68	0.00	0.00	0.00	0.23	0.23	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	30.86	0.33	0.16	0.00	0.00	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	103.70	2.00	0.36	0.18	0.36	0.36	0.36	0.91	1.28
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	33.95	1.06	0.00	0.53	0.00	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	28.81	0.00	0.00	0.00	0.00	0.00	0.00	0.60	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	230.05	1.64	0.98	0.66	0.98	0.00	3.61	0.66	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	21.79	0.98	0.00	0.00	0.00	0.00	0.16	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	115.53	1.41	0.00	0.00	0.18	0.35	1.94	1.59	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	18.99	0.00	0.00	0.00	0.00	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	39.53	1.38	0.00	0.00	0.00	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	28.60	0.64	0.00	0.00	0.00	0.32	0.32	0.64	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	220.73	2.07	0.34	0.34	1.03	0.34	3.45	1.72	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	568.90	5.06	2.53	5.06	2.53	0.00	5.06	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	91.56	2.01	0.22	0.22	0.22	0.22	1.34	1.56	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	33.87	0.00	0.00	0.42	0.00	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	55.07	0.95	0.00	0.24	0.00	0.00	0.95	0.71	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	27.04	0.00	0.00	0.00	0.43	0.00	1.29	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	514.58	36.11	0.00	9.03	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	25.66	1.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	58.61	1.35	0.00	0.00	0.45	0.00	0.90	1.80	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	17.46	0.79	0.00	0.00	0.00	0.00	0.79	0.79	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	24.14	0.00	0.00	0.00	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	54.49	1.14	0.00	0.00	0.00	0.38	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	17.60	0.65	0.33	0.00	0.00	0.00	0.33	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	21.35	1.31	0.00	0.44	0.00	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	74.18	3.17	0.00	0.00	0.00	0.00	0.90	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	18.52	0.88	0.00	0.00	0.00	0.88	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	24.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	28.27	0.50	0.00	0.00	0.50	0.50	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.23	1.53	0.00	0.00	0.00	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.33	2.72	0.30	0.00	0.00	0.30	0.60	0.30	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	76.03	3.76	0.00	0.66	0.22	0.22	0.22	0.88	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	18.30	0.68	0.00	0.00	0.00	0.00	0.00	0.68	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	378.11	5.11	0.00	5.11	0.00	0.00	5.11	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	23.17	0.61	0.00	0.00	0.00	0.00	0.61	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	25.18	0.94	0.00	0.00	0.63	0.00	1.26	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	26.94	0.61	0.00	0.30	0.30	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	26.90	0.00	0.79	0.00	0.00	0.00	0.00	0.79	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	174.58	11.34	0.00	1.13	0.00	2.27	10.20	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	323.70	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	68.57	2.48	0.75	0.50	0.62	0.37	1.86	1.37	0.75
Myoblast, donor2	11322-117D8	154.39	1.53	1.15	0.00	0.38	0.38	3.45	1.34	2.30
Myoblast, donor3	11398-118D3	126.12	2.19	1.35	0.17	0.00	0.00	1.35	3.53	0.34
NK T cell leukemia cell line:KHYG-1	10777-110G3	207.52	2.63	0.73	0.73	1.02	0.58	1.46	1.61	1.90
Natural Killer Cells, donor1	11230-116C6	298.29	2.46	0.62	0.31	0.92	0.31	0.92	1.23	0.92
Natural Killer Cells, donor2	11311-117C6	273.51	1.51	2.71	0.00	1.51	1.51	0.90	1.51	2.11
Natural Killer Cells, donor3	11387-118C1	262.83	2.58	1.84	0.00	1.66	1.10	2.21	0.92	2.76
Neural stem cells, donor1	11275-116H6	389.80	5.44	0.73	0.36	0.00	0.00	2.90	3.99	3.27
Neural stem cells, donor2	11352-117H2	427.49	9.63	1.93	0.00	0.00	0.00	7.70	1.93	0.00
Neurons, donor1	11494-119E9	436.95	6.83	1.14	0.00	1.14	1.14	9.10	7.97	3.41
Neurons, donor2	11574-120E8	320.34	1.98	1.54	0.00	0.66	0.66	3.30	4.18	1.76
Neurons, donor3	11655-122E8	302.56	4.11	11.51	0.82	2.47	0.00	9.87	5.76	3.29
Neutrophils, donor1	11233-116C9	212.51	12.99	3.71	0.93	0.93	0.00	1.86	2.78	3.71
Neutrophils, donor2	11314-117C9	150.74	2.90	11.60	5.80	0.00	5.80	0.00	0.00	8.70
Neutrophils, donor3	11390-118C4	167.37	5.50	0.00	1.22	0.00	0.00	1.83	2.44	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	154.83	1.19	0.83	0.00	0.24	0.12	0.71	0.24	0.47
Nucleus Pulposus Cell, donor2	11409-118E5	88.24	0.98	0.33	0.33	0.33	0.00	1.63	0.33	0.98
Nucleus Pulposus Cell, donor3	11462-119B4	109.50	0.60	0.60	0.40	0.00	0.20	0.40	0.60	1.00
Olfactory epithelial cells, donor1	11933-125I7	81.21	1.79	1.79	0.83	1.10	0.41	0.96	0.41	0.14
Olfactory epithelial cells, donor2	11934-125I8	116.66	1.74	3.18	0.29	0.72	0.87	1.74	1.59	1.74
Olfactory epithelial cells, donor3	11935-125I9	66.85	1.70	0.11	0.23	0.34	0.34	0.79	0.34	0.68
Olfactory epithelial cells, donor4	11936-126A1	92.04	1.17	0.49	0.39	0.58	0.29	0.97	0.29	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	190.78	4.21	1.81	0.00	1.20	0.60	1.20	2.41	0.60
Osteoblast - differentiated, donor1	11276-116H7	56.58	3.40	0.00	0.00	0.21	0.00	0.21	0.43	0.43
Osteoblast - differentiated, donor2	11353-117H3	19.43	0.00	0.00	0.00	1.14	0.00	1.14	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	63.31	1.24	0.62	0.00	1.24	0.00	1.24	0.00	0.00
Osteoblast, donor1	11277-116H8	131.53	1.76	0.00	0.20	0.39	0.20	1.17	3.52	0.39
Osteoblast, donor2	11354-117H4	249.32	2.81	0.70	0.70	0.70	0.70	4.92	4.21	0.70
Osteoblast, donor3	11426-118G4	137.92	2.84	0.36	0.71	0.36	0.53	2.31	3.02	0.71
Pancreatic stromal cells, donor1	11249-116E7	165.52	1.94	1.01	0.17	0.59	0.42	2.11	2.02	0.59
Pericytes, donor1	11491-119E6	96.80	0.67	0.11	0.11	0.00	0.00	0.22	0.33	0.11
Pericytes, donor2	11571-120E5	112.96	0.68	0.45	0.45	0.00	0.00	0.68	0.23	1.58
Pericytes, donor3	11652-122E5	122.07	1.63	0.41	1.42	0.20	0.00	1.02	0.81	1.63
Perineurial Cells, donor1	11499-119F5	197.56	2.37	0.45	0.23	0.11	0.00	1.92	1.36	0.57
Perineurial Cells, donor2	11579-120F4	199.57	1.38	0.37	0.09	0.28	0.28	2.30	2.48	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	368.14	1.59	0.32	0.32	0.00	0.00	0.64	0.32	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	235.80	2.69	0.73	0.24	0.49	0.24	1.47	0.73	2.45
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	253.53	2.46	0.13	0.26	1.04	0.52	1.94	1.55	1.81
Placental Epithelial Cells, donor1	11278-116H9	143.50	1.20	0.48	0.48	0.24	0.24	0.48	1.67	0.24
Placental Epithelial Cells, donor2	11355-117H5	100.91	1.11	2.22	0.00	0.00	0.00	5.54	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	178.07	1.96	1.37	0.00	0.79	0.39	3.34	1.77	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	33.54	0.95	0.63	0.00	0.00	0.32	0.63	1.58	0.32
Preadipocyte - breast, donor1	11467-119B9	27.95	0.94	0.19	0.75	0.00	0.00	0.94	0.00	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	53.52	1.44	0.26	0.13	0.00	0.13	0.26	0.13	1.31
Preadipocyte - breast, donor2	11328-117E5	50.66	1.13	0.45	0.00	0.45	0.68	1.13	0.45	1.58
Preadipocyte - omental, donor1	11468-119C1	44.22	1.92	0.00	0.11	0.00	0.11	0.21	0.32	0.53
Preadipocyte - omental, donor2	11329-117E6	34.92	0.87	0.00	0.44	0.00	0.00	0.00	0.44	0.87
Preadipocyte - omental, donor3	11403-118D8	65.75	2.01	0.72	0.43	0.57	0.14	0.57	1.15	0.57
Preadipocyte - perirenal, donor1	11469-119C2	34.45	0.00	0.00	0.00	0.00	0.00	0.98	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	73.09	1.23	0.00	0.31	0.00	0.31	0.61	2.46	0.31
Preadipocyte - subcutaneous, donor2	11356-117H6	344.24	5.31	2.83	1.24	2.48	2.12	7.79	8.68	5.67
Preadipocyte - subcutaneous, donor3	11428-118G6	196.68	2.89	0.34	0.34	0.51	1.02	3.75	4.09	1.53
Preadipocyte - visceral, donor1	11280-116I2	280.93	3.63	1.21	1.58	0.56	0.28	2.70	5.96	0.84
Preadipocyte - visceral, donor2	11357-117H7	213.98	3.68	1.38	0.46	1.38	0.00	3.22	0.92	1.84
Preadipocyte - visceral, donor3	11429-118G7	208.15	2.61	0.73	0.63	0.63	0.21	3.76	3.55	3.55
Prostate Epithelial Cells (polarized), donor1	11253-116F2	250.57	4.22	1.36	0.60	1.06	0.60	1.51	3.02	1.51
Prostate Epithelial Cells, donor2	11331-117E8	65.27	2.03	0.27	0.68	0.27	0.54	0.81	0.95	1.35
Prostate Epithelial Cells, donor3	11404-118D9	55.48	2.20	0.37	0.98	0.61	0.55	0.61	0.67	1.22
Prostate Stromal Cells, donor1	11254-116F3	176.77	3.30	1.82	0.46	0.23	0.80	3.42	3.76	0.57
Prostate Stromal Cells, donor2	11332-117E9	224.84	4.12	3.05	1.43	2.69	1.79	5.38	3.77	2.87
Prostate Stromal Cells, donor3	11405-118E1	103.13	1.56	0.83	0.31	0.73	0.10	1.98	0.63	1.36
Renal Cortical Epithelial Cells, donor1	11516-119H4	145.26	5.11	0.00	0.36	0.00	0.36	0.00	2.19	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	142.57	4.64	0.42	0.35	0.49	0.21	1.46	1.66	0.76
Renal Epithelial Cells, donor1	11517-119H5	191.23	2.54	0.51	0.00	0.00	0.00	2.03	4.06	0.00
Renal Epithelial Cells, donor2	11597-120H4	217.66	4.98	1.42	0.71	1.42	1.42	7.11	2.85	2.85
Renal Epithelial Cells, donor3	11678-122H4	174.04	5.08	1.38	0.42	0.42	0.00	0.64	1.38	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	145.70	0.68	0.68	0.00	0.68	0.00	4.77	0.68	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	156.73	0.81	0.40	0.54	0.27	0.40	2.02	4.58	1.62
Renal Glomerular Endothelial Cells, donor3	11675-122H1	299.94	5.11	5.77	0.67	4.66	2.44	4.22	7.55	4.66
Renal Glomerular Endothelial Cells, donor4	11783-124B1	96.49	0.00	0.67	0.00	0.67	0.67	1.33	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	186.19	2.42	0.88	0.66	0.00	0.00	1.32	2.20	0.44
Renal Mesangial Cells, donor2	11598-120H5	158.63	1.88	0.63	0.63	0.00	0.63	1.88	1.88	1.88
Renal Mesangial Cells, donor3	11679-122H5	108.47	2.22	0.00	0.28	0.28	0.00	1.66	0.55	0.83
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	218.76	2.95	0.54	0.54	0.00	0.27	1.07	4.56	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	116.81	3.80	0.84	0.84	0.84	0.42	2.11	1.27	0.84
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	234.69	2.70	1.16	1.35	2.12	0.77	4.44	4.24	1.93
Retinal Pigment Epithelial Cells, donor0	11215-116A9	246.32	4.41	1.30	1.56	0.26	0.52	3.37	1.56	1.30
Retinal Pigment Epithelial Cells, donor1	11528-119I7	142.97	3.98	0.57	1.42	0.57	0.28	1.14	0.57	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	206.85	8.23	1.03	1.03	0.00	1.03	1.03	4.12	4.12
Retinal Pigment Epithelial Cells, donor3	11689-122I6	109.14	4.01	0.25	0.50	0.00	0.00	0.25	1.25	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	170.39	3.07	0.27	0.40	0.27	0.27	0.53	1.74	0.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	107.21	0.89	0.89	0.00	0.00	0.00	0.89	0.89	2.68
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	308.21	3.30	0.00	0.00	2.20	0.55	4.95	3.30	2.75
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	299.89	3.48	0.00	0.00	0.58	0.58	8.12	3.48	2.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	309.72	2.34	0.39	0.26	0.13	0.39	7.28	6.37	1.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	288.78	3.97	1.19	0.50	1.79	0.79	7.55	3.67	2.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	270.04	2.23	0.78	0.33	0.56	0.67	5.69	5.24	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	360.72	2.73	1.86	0.87	1.24	0.99	8.93	4.59	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	284.72	3.15	2.10	1.17	1.52	1.05	5.71	3.96	3.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	342.77	5.78	3.24	0.92	1.39	1.39	9.71	5.78	3.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	234.25	3.01	0.27	0.14	0.96	0.27	4.79	5.20	1.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	273.05	1.97	1.82	0.00	1.82	0.45	7.71	3.33	3.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	234.92	2.51	0.90	0.36	0.18	0.54	5.91	4.30	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	228.10	1.86	1.00	0.43	1.15	0.72	4.30	5.59	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	262.17	3.76	1.29	0.54	0.75	0.43	5.79	3.33	2.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	298.05	4.20	0.66	0.22	0.44	0.22	8.41	3.54	1.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	212.97	1.34	0.76	0.57	0.19	0.00	5.16	4.21	2.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	283.59	2.89	1.58	0.56	0.19	0.37	6.61	4.10	1.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	286.93	1.69	0.75	0.38	0.75	0.56	6.39	6.20	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	243.65	2.92	0.93	0.27	0.53	0.13	5.31	5.57	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	340.50	3.80	2.24	0.49	1.07	1.17	9.64	5.55	2.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	300.38	3.63	1.53	0.76	0.57	0.57	7.07	5.16	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	224.59	2.35	0.96	0.32	0.64	0.11	5.66	4.81	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	271.90	2.52	1.12	0.28	1.68	1.96	8.97	4.77	3.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	290.36	3.93	0.68	0.68	1.03	0.34	6.49	6.15	2.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	222.99	1.64	0.55	0.18	1.64	0.91	4.01	4.01	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	285.00	2.94	0.98	0.86	1.84	1.35	6.62	3.31	3.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	292.82	3.49	1.75	0.67	1.07	0.81	9.67	3.90	2.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	228.09	1.89	1.89	1.18	0.47	0.47	6.60	7.08	2.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	314.49	3.97	1.59	0.79	1.59	0.60	6.55	4.37	2.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	265.42	3.98	1.40	0.23	2.10	0.47	5.38	5.85	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	212.33	1.45	1.24	0.21	0.83	0.41	4.15	4.77	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	279.17	5.09	3.54	0.88	2.65	0.88	4.87	2.65	2.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	282.20	4.39	0.63	0.63	0.84	0.21	9.82	5.85	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	244.00	2.29	1.08	0.27	1.35	0.54	5.65	5.52	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	349.44	4.77	0.51	0.34	0.51	0.51	10.22	4.77	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	310.40	3.86	1.35	0.77	1.93	1.35	9.64	6.17	2.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	246.56	3.27	1.38	0.86	1.20	0.69	5.67	4.64	1.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	344.16	4.39	1.10	1.10	0.82	0.41	10.97	5.35	1.65
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	336.88	5.42	2.63	0.66	1.81	1.31	12.64	6.90	2.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	219.69	2.90	0.34	0.34	0.34	0.34	5.45	5.97	1.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	369.30	3.85	1.78	1.04	1.33	0.89	8.88	6.36	2.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	278.55	3.20	0.27	0.53	0.80	0.27	7.20	4.53	1.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	219.15	0.97	0.14	0.14	0.14	0.14	3.87	3.32	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	269.77	1.90	1.19	0.24	0.95	0.48	5.95	3.81	1.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	372.65	2.62	0.60	0.60	1.21	0.40	8.87	3.43	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	184.96	1.32	0.47	0.19	0.47	0.09	3.39	2.83	1.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	230.93	2.45	0.70	0.70	1.05	0.00	6.64	3.84	1.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	227.57	3.32	0.60	0.30	0.60	0.00	7.86	3.63	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	216.01	1.10	1.10	0.24	0.73	0.37	5.02	3.18	1.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	387.02	2.77	0.44	0.73	1.02	0.44	7.71	4.37	0.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	195.31	2.43	0.61	0.00	0.00	0.00	6.69	4.26	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	207.66	0.60	0.30	0.00	0.30	1.21	4.22	4.82	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	204.70	2.26	0.90	0.23	0.23	0.68	6.56	3.39	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	265.09	2.40	0.30	0.00	1.80	0.90	8.39	3.59	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	180.42	0.35	0.59	0.12	0.24	0.59	4.25	2.60	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	138.95	0.85	0.85	0.43	1.28	1.49	3.42	2.13	3.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	170.68	2.40	0.60	0.00	0.60	0.60	6.61	2.40	2.40
Schwann Cells, donor1	11498-119F4	199.92	2.63	0.19	0.56	0.00	0.75	1.88	1.88	2.63
Schwann Cells, donor2	11578-120F3	149.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	10.21
Schwann Cells, donor3	11659-122F3	178.77	2.41	4.16	0.66	3.94	1.31	1.97	2.63	3.51
Sebocyte, donor1	11220-116B5	176.38	2.19	0.00	0.55	0.00	0.00	0.00	1.10	0.00
Sebocyte, donor2	11301-117B5	126.84	2.30	0.00	0.92	0.46	0.00	1.84	2.30	2.76
Sebocyte, donor3	11378-118B1	94.81	1.24	0.00	0.41	0.21	0.21	1.03	0.82	0.41
Sertoli Cells, donor1	11255-116F4	152.41	3.31	0.00	0.00	1.66	0.00	1.66	3.31	1.66
Sertoli Cells, donor2	11333-117F1	110.15	8.47	5.65	0.00	0.00	0.00	2.82	0.00	2.82
Skeletal Muscle Cells, donor1	11281-116I3	274.93	2.29	0.70	0.44	0.53	0.18	1.58	1.41	0.44
Skeletal Muscle Cells, donor2	11358-117H8	41.20	0.72	0.00	0.00	0.00	0.00	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	256.66	5.02	0.84	0.00	0.00	1.67	3.34	3.34	0.84
Skeletal Muscle Cells, donor4	11451-119A2	240.82	2.51	2.36	0.94	0.63	1.26	3.77	3.77	2.67
Skeletal Muscle Cells, donor5	11455-119A6	206.32	2.23	0.45	1.04	0.15	0.59	2.82	2.82	2.53
Skeletal Muscle Cells, donor6	11459-119B1	271.33	5.39	1.39	2.00	0.62	1.08	3.54	5.39	2.31
Skeletal Muscle Satellite Cells, donor1	11240-116D7	173.76	2.39	0.88	0.00	1.13	0.50	1.26	1.39	1.01
Skeletal Muscle Satellite Cells, donor2	11321-117D7	193.77	4.42	1.14	1.00	1.00	0.43	1.71	1.00	1.28
Skeletal Muscle Satellite Cells, donor3	11397-118D2	304.57	5.36	1.19	1.29	0.89	0.99	5.16	5.06	1.88
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	222.17	3.62	0.42	0.76	0.51	0.42	2.61	2.11	0.59
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	212.79	0.72	0.72	2.17	0.00	0.72	2.90	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	73.20	0.41	0.28	0.14	0.00	0.14	0.55	1.10	0.69
Skin - palm, donor1	10286-104F7	104.76	5.37	0.00	0.00	0.00	0.00	0.00	0.00	8.06
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	49.16	0.72	0.72	0.14	0.14	0.29	0.86	0.86	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	107.14	2.45	0.00	0.82	0.00	0.82	3.27	2.45	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	65.56	0.65	0.26	0.52	0.13	0.00	0.39	1.17	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	66.17	1.67	0.00	0.42	0.14	0.28	0.97	0.83	0.42
Small Airway Epithelial Cells, donor2	11334-117F2	103.80	1.97	0.56	1.27	0.42	0.42	0.84	1.69	1.69
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	201.08	2.33	1.06	1.90	0.00	0.42	1.69	4.86	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	68.13	2.40	0.22	1.27	0.30	0.30	1.12	0.52	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	64.19	2.16	0.93	0.31	0.62	0.31	1.85	0.62	1.54
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	89.82	0.89	0.44	0.67	0.22	0.44	1.11	2.00	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	67.01	1.18	0.00	0.00	0.59	0.00	1.18	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	207.73	0.88	0.00	0.88	0.22	0.44	1.77	1.10	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	65.37	0.39	0.00	0.39	0.00	0.00	0.79	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	50.99	0.77	0.00	0.00	0.00	0.00	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	91.07	2.00	2.00	0.00	3.00	1.00	1.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	62.95	1.06	0.00	0.13	0.00	0.13	0.53	0.80	0.27
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	115.70	3.99	0.22	0.00	0.44	0.22	1.33	1.33	1.99
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	31.50	0.64	0.13	0.26	0.13	0.00	0.77	0.64	0.77
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	111.03	0.33	1.63	0.65	0.33	0.00	0.65	1.30	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	80.03	0.89	0.30	0.00	0.00	0.59	0.89	0.30	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	63.92	0.71	0.28	0.00	0.14	0.00	0.85	0.43	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	94.84	1.14	0.65	0.49	0.00	0.00	1.14	0.65	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	112.34	1.22	0.30	0.30	0.00	0.61	1.22	0.30	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	110.62	2.27	0.25	0.00	0.00	0.00	1.77	1.52	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	232.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	73.91	0.48	0.95	0.00	0.95	0.00	1.43	0.95	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	105.44	1.77	0.29	0.29	0.44	0.15	0.59	1.18	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	133.45	1.94	0.65	1.08	0.43	0.86	1.51	3.01	1.29
Smooth Muscle Cells - Colonic, donor3	11396-118D1	170.35	1.68	0.52	0.52	0.73	0.52	2.41	2.31	0.94
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	80.28	0.77	0.31	0.15	0.00	0.00	1.39	2.32	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	43.12	0.00	0.00	0.00	1.08	1.08	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	72.92	0.60	0.60	0.00	0.00	0.30	0.60	1.49	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	184.70	1.71	0.68	0.34	0.34	0.00	3.07	3.41	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	149.99	0.79	0.94	0.08	0.47	0.16	0.71	0.31	0.94
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	106.58	4.23	0.30	1.11	0.00	0.10	1.11	0.70	0.60
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	94.66	1.37	0.68	0.46	0.68	0.23	2.28	1.37	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	61.59	1.21	1.21	0.60	0.00	0.00	0.00	0.00	1.21
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	442.16	7.42	2.38	6.89	0.53	1.32	8.21	8.48	1.85
Smooth Muscle Cells - Prostate, donor1	11257-116F6	178.57	3.33	0.27	0.13	0.27	0.00	1.33	2.80	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	152.89	2.38	0.75	0.13	1.00	1.25	2.38	2.13	3.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	40.08	1.27	1.01	0.25	0.00	0.00	0.00	0.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	118.66	1.21	0.00	0.00	0.45	0.15	1.06	1.06	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	72.02	0.75	0.75	0.00	0.75	1.50	1.50	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	867.08	1.29	1.29	0.00	2.58	3.88	3.88	2.58	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	94.87	0.93	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	93.40	1.01	0.00	1.01	1.01	0.50	2.52	1.01	1.01
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	31.65	0.94	0.94	0.63	0.00	0.31	0.94	0.63	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	39.23	0.29	0.00	0.59	0.59	0.00	0.29	0.59	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	347.22	4.75	0.50	0.75	0.33	0.08	2.83	5.25	0.42
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	93.90	1.40	1.40	0.00	0.47	0.00	0.47	0.47	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	68.36	2.01	0.43	0.58	0.00	0.14	1.15	0.29	0.14
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	123.14	2.29	0.25	0.00	0.51	0.25	1.02	1.53	1.27
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	93.83	0.75	0.75	0.00	0.19	0.38	1.69	1.32	0.94
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	256.01	2.66	0.56	1.26	0.70	0.28	2.79	3.21	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	115.63	2.77	0.17	0.50	0.00	0.08	0.92	0.59	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	23.81	0.00	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	63.61	1.71	0.24	0.49	0.24	0.00	1.47	0.24	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	108.04	0.88	1.10	0.66	0.66	0.22	1.55	1.10	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	73.73	2.05	0.29	0.29	0.88	0.00	0.88	0.59	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	68.41	0.97	0.39	0.00	0.58	0.00	0.78	0.78	1.17
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	49.45	0.26	0.26	0.00	0.00	0.00	0.53	0.79	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	75.13	1.12	0.37	0.74	0.00	0.00	0.74	0.37	1.49
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	46.71	2.16	0.00	0.00	0.00	0.00	0.36	0.00	0.72
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	32.93	0.00	0.57	0.00	0.00	0.00	1.14	0.85	1.42
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	157.94	1.58	1.58	0.79	1.18	0.79	3.15	2.76	2.36
Smooth muscle cells - airway, control, donor1	11966-126D4	67.81	1.78	0.51	0.25	0.51	0.51	1.27	0.51	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	68.68	0.40	0.40	0.00	0.40	0.40	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	51.83	1.67	0.42	0.00	1.25	0.42	1.25	0.42	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	73.80	0.00	0.92	0.00	0.00	0.00	0.46	0.46	1.38
Synoviocyte, donor1	11291-117A4	83.49	2.19	1.18	0.67	0.34	0.50	1.51	1.01	0.34
Synoviocyte, donor2	11368-117I9	101.41	1.17	0.34	0.34	0.34	0.50	2.35	0.34	0.50
Synoviocyte, donor3	11440-118H9	71.04	2.46	0.89	0.00	0.00	0.22	0.67	0.22	1.34
Trabecular Meshwork Cells, donor1	11532-120A2	279.08	3.57	0.00	1.07	0.71	0.36	1.79	2.50	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	150.64	1.98	0.00	0.00	0.00	0.00	1.98	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	220.43	2.08	0.46	0.46	0.00	0.23	2.32	2.32	0.93
Tracheal Epithelial Cells, donor1	11292-117A5	92.33	1.58	0.07	0.93	0.07	0.22	0.79	0.86	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	61.85	0.77	0.00	0.77	0.77	0.00	0.39	0.39	0.77
Tracheal Epithelial Cells, donor3	11441-118I1	64.14	1.15	0.57	0.57	0.00	0.00	2.29	1.72	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	173.34	2.58	0.37	0.37	0.12	0.25	0.86	0.74	0.74
Urethra, donor2	10319-105A4	145.67	7.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	68.81	2.39	0.00	0.80	0.00	0.00	0.00	1.06	0.00
Urothelial Cells, donor2	11600-120H7	64.89	2.00	0.40	0.40	0.00	0.00	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	61.89	1.83	0.23	0.00	0.00	0.23	0.46	0.23	0.46
Urothelial cells, donor0	11216-116B1	98.30	4.01	0.22	0.22	0.00	0.45	0.22	0.45	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	218.89	2.67	0.00	0.00	0.00	0.89	0.00	0.89	1.78
Whole blood (ribopure), donor090309, donation2	12180-129A2	200.15	2.86	0.00	1.43	0.00	1.43	1.43	2.86	1.43
Whole blood (ribopure), donor090309, donation3	12181-129A3	190.98	4.79	0.68	1.37	0.00	0.00	1.37	0.68	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	234.84	2.07	0.34	0.00	0.34	0.34	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	215.56	3.49	1.16	1.16	0.58	0.00	0.00	1.16	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	186.38	8.33	0.00	0.00	0.00	1.04	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	212.01	1.84	0.92	0.00	0.92	0.00	0.92	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	179.84	2.74	0.91	1.83	0.00	0.00	1.83	0.91	2.74
Wilms' tumor cell line:G-401	10809-111A8	354.79	2.34	0.86	0.25	1.73	1.60	7.90	6.66	2.22
Wilms' tumor cell line:HFWT	10597-108E3	161.05	4.40	0.00	0.00	0.88	0.00	0.88	0.88	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	284.35	6.42	2.51	1.40	2.23	1.40	4.19	2.51	2.23
achilles tendon, donor2	10292-104G4	161.19	2.07	4.13	0.00	0.00	0.00	0.00	0.00	4.13
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	442.35	8.67	6.12	1.02	1.78	1.53	4.59	9.94	7.39
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	694.20	6.73	2.79	0.70	0.70	0.93	10.22	8.36	1.86
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	510.92	2.73	2.97	0.12	0.71	0.71	10.80	6.89	3.80
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	454.70	2.45	5.44	0.54	2.72	1.36	13.06	20.68	8.71
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	267.31	4.78	3.09	0.28	1.97	1.12	5.62	3.37	9.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	228.82	0.21	1.48	0.00	0.21	0.00	5.08	2.11	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	325.84	1.91	2.18	0.54	0.82	1.09	3.81	2.72	4.08
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	277.16	3.53	3.08	0.88	1.76	0.88	1.32	3.08	4.41
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	320.15	2.86	2.04	0.41	2.86	0.00	2.45	2.86	6.53
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	313.74	2.72	1.55	1.16	3.11	1.16	3.88	5.05	7.38
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	474.17	6.62	2.39	1.29	5.52	2.94	5.70	5.52	11.22
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	471.96	7.80	0.00	0.00	3.90	0.00	11.70	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	403.65	2.09	1.86	0.23	2.79	1.16	6.51	10.46	3.95
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	811.14	8.28	5.95	0.78	4.14	3.88	11.13	12.43	8.03
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	698.46	6.14	7.01	0.29	15.20	9.94	7.01	9.06	52.31
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	428.04	4.18	0.46	0.46	0.93	1.39	4.18	4.18	1.86
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	206.04	3.70	0.41	0.00	2.47	0.41	0.41	1.65	2.88
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	201.67	3.38	0.31	0.00	0.61	1.53	2.46	2.15	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	399.83	8.11	2.13	0.00	0.43	0.43	5.12	5.97	3.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	361.22	5.76	0.61	0.61	0.61	0.00	3.03	3.03	1.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	388.98	7.46	0.96	0.00	0.48	1.20	4.09	5.30	1.20
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	399.15	11.14	1.78	2.23	1.56	1.34	4.90	6.24	6.90
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	453.62	18.68	1.33	3.34	1.33	0.33	3.67	11.34	1.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	654.09	18.58	0.00	0.00	1.86	1.86	1.86	7.43	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	447.85	5.27	3.01	0.38	1.51	2.64	4.52	2.64	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	389.90	6.54	0.87	0.00	2.18	0.00	8.72	6.11	3.49
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	367.39	7.50	0.00	0.00	1.87	0.00	5.62	1.87	1.87
adenocarcinoma cell line:IM95m	10796-110I4	169.80	2.35	0.71	0.24	0.00	1.41	0.71	0.47	0.71
adipose tissue, adult, pool1	10010-101C1	157.76	4.65	0.31	0.31	0.16	0.62	0.00	0.31	0.00
adipose, donor1	10184-103D4	1166.37	49.84	7.62	3.52	2.93	3.52	11.14	7.62	5.28
adipose, donor2	10185-103D5	175.59	7.30	1.22	0.00	1.22	0.00	2.03	2.03	1.22
adipose, donor3	10186-103D6	356.97	6.26	3.27	0.82	1.63	1.36	5.45	3.54	3.27
adipose, donor4	10187-103D7	1105.98	19.94	8.67	5.20	6.07	2.60	15.60	13.00	8.67
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	232.31	3.16	0.00	0.79	0.95	0.47	5.68	4.10	0.79
adrenal gland, adult, pool1	10081-102A9	80.03	0.00	0.00	0.00	0.00	0.00	0.00	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	149.28	3.20	0.53	0.67	0.13	0.67	0.67	0.93	1.20
alveolar cell carcinoma cell line:SW 1573	10708-109H6	255.11	1.43	0.71	0.36	1.43	0.71	4.29	1.07	0.71
amniotic membrane cells, donor1	12235-129G3	91.81	3.48	0.70	0.46	0.23	0.00	0.70	0.70	0.23
amniotic membrane cells, donor2	12236-129G4	206.92	1.69	0.68	0.00	1.01	0.34	2.37	0.68	1.35
amniotic membrane cells, donor3	12237-129G5	130.80	5.60	0.29	1.47	0.29	0.59	1.77	1.18	0.88
amygdala - adult, donor10196	10167-103B5	179.06	2.37	0.00	0.00	0.00	0.00	1.19	1.19	0.00
amygdala, adult, donor10252	10151-102I7	202.16	6.08	1.62	1.62	0.20	0.41	3.45	1.01	1.82
amygdala, newborn, donor10223	10360-105E9	81.34	4.52	0.97	0.32	0.32	0.00	1.29	1.61	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	104.16	1.53	0.38	0.13	0.51	0.00	0.38	0.25	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	245.77	5.74	3.75	1.32	2.87	1.54	6.18	5.07	6.18
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	446.94	2.67	1.34	0.33	2.34	0.67	2.34	1.00	2.34
aorta, adult, pool1	10052-101G7	162.99	4.12	0.98	0.39	1.37	0.00	0.78	0.59	1.37
appendix, adult	10189-103D9	341.54	3.88	3.10	0.00	1.16	0.00	2.33	3.10	2.33
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	281.00	9.29	1.38	1.03	0.69	0.34	0.69	2.75	1.72
artery, adult	10190-103E1	146.74	8.15	1.36	1.36	0.00	0.00	0.00	1.36	4.08
astrocytoma cell line:TM-31	10425-106D2	151.97	1.59	1.01	0.00	0.14	0.29	1.45	0.58	1.74
b cell line:RPMI1788	10427-106D4	278.81	1.64	0.45	0.89	0.59	0.59	1.19	4.01	2.38
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.74	1.66	0.55	0.00	0.28	0.00	0.55	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	204.32	2.98	0.50	1.69	0.69	0.30	3.08	4.37	0.30
bile duct carcinoma cell line:TFK-1	10496-107C1	142.44	3.68	0.17	0.84	0.33	0.00	0.84	2.01	1.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	206.36	2.80	2.24	0.00	2.24	2.80	2.24	2.24	0.56
bladder, adult, pool1	10011-101C2	240.21	5.11	1.09	0.43	0.43	0.54	1.52	0.98	1.09
blood, adult, pool1	10053-101G8	128.45	0.00	2.21	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	76.21	1.71	0.00	0.86	0.00	0.00	0.86	0.86	0.00
bone marrow, adult	10192-103E3	207.17	6.07	2.02	0.67	0.67	1.35	3.37	3.37	2.70
brain, adult, donor1	10084-102B3	110.71	2.05	0.00	0.00	1.03	0.00	1.03	0.00	2.05
brain, adult, pool1	10012-101C3	185.19	6.12	1.00	0.56	1.56	0.11	1.45	1.11	0.67
brain, fetal, pool1	10085-102B4	232.41	2.67	0.00	0.00	0.00	0.00	2.67	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	156.59	7.27	0.66	0.33	0.33	0.00	1.32	1.32	1.65
breast carcinoma cell line:MDA-MB-453	10419-106C5	251.89	5.12	0.12	0.75	0.25	0.25	1.37	1.12	0.37
breast, adult, donor1	10080-102A8	66.92	1.89	0.63	0.00	0.00	0.00	0.00	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	268.94	2.16	1.78	0.76	0.89	1.02	0.76	1.65	2.79
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	521.96	10.51	0.93	1.24	1.55	2.16	0.93	3.09	2.47
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	196.15	0.92	0.92	0.23	0.23	0.69	1.15	0.46	1.61
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	197.54	2.66	0.73	0.00	1.94	1.45	2.91	3.15	2.18
carcinoid cell line:NCI-H1770	10703-109H1	314.07	5.17	0.47	1.41	0.94	0.47	2.35	1.41	0.00
carcinoid cell line:NCI-H727	10735-110B6	173.37	7.22	0.55	0.77	0.55	0.11	0.88	2.08	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	258.90	0.63	0.32	0.00	0.00	1.58	4.12	2.85	3.17
carcinosarcoma cell line:JHUCS-1	10642-109A3	421.89	1.60	1.86	0.80	4.26	2.93	3.73	3.73	4.53
caudate nucleus - adult, donor10196	10177-103C6	217.60	8.06	0.00	0.00	0.00	0.00	1.15	1.15	2.30
caudate nucleus, adult, donor10252	10164-103B2	184.23	2.51	1.17	0.50	0.84	0.33	5.69	0.84	0.84
caudate nucleus, adult, donor10258	10379-105H1	114.62	1.53	0.76	0.00	0.76	0.00	2.29	0.76	0.00
caudate nucleus, newborn, donor10223	10354-105E3	98.88	2.56	0.73	0.73	0.37	0.00	2.56	0.73	0.73
cerebellum - adult, donor10196	10173-103C2	428.25	14.57	0.00	0.00	0.00	0.00	0.00	0.00	2.91
cerebellum, adult, donor10252	10166-103B4	389.44	5.34	1.71	1.49	0.43	0.43	1.07	2.14	2.99
cerebellum, adult, pool1	10083-102B2	209.73	6.55	0.69	0.34	1.03	1.03	0.69	0.34	2.07
cerebellum, newborn, donor10223	10357-105E6	276.49	4.15	3.32	1.66	0.00	0.00	0.83	3.32	1.66
cerebral meninges, adult	10188-103D8	164.90	5.04	0.50	0.00	0.00	0.50	2.77	0.76	0.50
cerebrospinal fluid, donor2	10294-104G6	123.52	5.12	0.73	1.46	0.00	0.00	2.19	0.00	4.39
cervical cancer cell line:D98-AH2	10552-107I3	88.71	0.72	0.14	0.29	0.14	0.00	0.72	0.72	0.43
cervical cancer cell line:ME-180	10553-107I4	148.48	2.65	0.83	0.50	0.33	0.17	0.66	2.15	0.66
cervix, adult, pool1	10013-101C4	299.43	7.03	0.52	0.31	0.31	0.31	3.04	1.47	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	80.68	1.53	0.56	0.14	0.14	0.14	0.84	0.98	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	117.56	9.14	0.00	0.00	0.00	0.00	1.31	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	337.41	2.49	1.24	0.62	0.75	0.37	2.24	3.48	2.61
choriocarcinoma cell line:SCH	10785-110H2	235.58	0.99	1.23	0.86	0.62	0.37	2.71	2.83	2.71
choriocarcinoma cell line:T3M-3	10618-108G6	211.09	2.37	0.00	0.00	0.00	0.47	3.56	3.32	1.19
chorionic membrane cells, donor1	12238-129G6	83.77	0.85	1.14	0.28	0.28	0.57	1.71	0.28	0.85
chorionic membrane cells, donor2	12239-129G7	125.88	1.59	0.40	0.40	0.30	0.20	0.80	0.70	0.40
chorionic membrane cells, donor3	12240-129G8	128.03	2.75	2.20	1.65	0.55	1.10	3.30	1.10	1.65
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	238.31	5.05	8.08	0.00	3.03	4.04	15.15	9.09	24.24
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	312.93	3.27	0.96	0.77	0.96	0.00	5.96	4.99	0.96
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	404.42	5.49	0.63	0.63	2.53	1.69	2.53	6.76	2.96
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	484.84	21.06	1.54	3.34	1.03	1.80	5.14	6.16	3.08
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	535.76	31.93	1.45	2.42	0.48	1.69	7.01	7.50	3.87
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	530.20	28.71	1.22	4.07	1.83	1.43	6.92	6.92	4.07
chronic myelogenous leukemia cell line:K562	10454-106G4	391.04	26.50	2.94	3.53	1.18	0.59	3.24	3.83	2.94
chronic myelogenous leukemia cell line:KU812	10409-106B4	688.31	10.69	1.82	3.39	0.00	0.78	9.38	6.52	2.87
clear cell carcinoma cell line:JHOC-5	10638-108I8	190.64	2.29	1.60	0.23	1.37	0.91	2.74	1.14	4.34
clear cell carcinoma cell line:TEN	10636-108I6	130.30	5.38	0.87	0.87	0.00	0.52	1.04	1.21	2.60
colon carcinoma cell line:CACO-2	10513-107D9	237.41	3.11	0.73	1.10	0.18	0.55	1.65	3.29	1.46
colon carcinoma cell line:COLO-320	10420-106C6	546.94	4.56	1.90	0.76	2.28	0.00	4.56	3.04	3.42
colon, adult, donor1	10082-102B1	161.84	0.00	1.19	0.00	1.19	0.00	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	253.45	4.35	0.59	0.82	0.35	0.12	1.18	0.94	0.35
colon, fetal, donor1	10070-101I7	161.30	1.85	0.62	0.00	0.00	0.00	0.00	1.24	0.00
common myeloid progenitor CMP, donor1	12130-128D6	366.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	189.10	1.70	1.70	0.00	0.42	0.85	1.70	4.67	2.55
cord blood derived cell line:COBL-a 24h infection	10453-106G3	363.90	3.47	3.17	0.30	0.15	0.15	4.38	6.79	2.41
cord blood derived cell line:COBL-a untreated	10449-106F8	331.09	3.53	1.97	0.56	0.85	0.71	3.95	8.88	3.81
corpus callosum, adult, pool1	10042-101F6	229.20	7.52	0.33	1.22	0.11	0.00	2.32	0.44	0.55
cruciate ligament, donor2	10295-104G7	204.24	3.24	0.81	0.00	0.81	0.00	0.00	0.81	4.86
diaphragm, fetal, donor1	10069-101I6	121.19	4.82	0.00	1.61	0.00	2.41	1.61	0.80	1.61
diencephalon, adult	10193-103E4	136.55	3.36	0.72	0.96	1.20	0.00	0.72	0.72	0.72
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	597.68	7.58	8.27	0.23	8.50	2.76	9.64	5.51	14.47
ductal cell carcinoma cell line:KLM-1	10438-106E6	240.28	4.10	0.26	0.51	0.77	0.26	2.56	1.54	0.51
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	138.42	2.17	0.48	1.44	0.24	0.00	3.13	2.17	1.44
ductus deferens, adult	10196-103E7	189.87	3.99	0.00	0.50	0.50	0.00	1.99	1.99	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	159.87	10.08	1.44	0.00	0.00	0.00	4.32	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	288.37	5.15	1.47	0.74	2.94	1.47	1.47	2.21	2.21
dura mater, adult, donor1	10041-101F5	248.26	6.19	0.58	0.74	0.25	0.25	1.24	0.91	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	143.68	3.55	0.89	2.66	0.89	0.44	4.89	8.44	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	197.46	6.59	1.15	1.43	0.72	1.00	3.73	6.88	1.15
embryonic pancreas cell line:1B2C6	10604-108F1	117.77	1.23	0.00	0.00	0.62	0.62	1.23	0.62	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	54.49	0.00	0.30	0.00	0.00	0.61	0.00	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	92.32	0.31	0.00	0.00	0.00	0.00	0.93	0.31	0.31
embryonic pancreas cell line:2C6	10603-108E9	115.58	0.00	0.00	0.00	0.00	0.00	2.63	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	140.78	0.67	0.00	0.67	0.00	0.67	0.67	1.68	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	170.36	0.54	1.63	0.00	0.54	0.18	1.09	0.91	1.63
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	119.00	5.47	1.29	1.61	1.13	0.32	1.77	3.06	3.86
epidermoid carcinoma cell line:A431	10426-106D3	359.26	5.56	0.56	0.89	0.44	0.11	2.78	4.11	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	208.42	3.08	0.44	0.88	0.22	0.00	1.21	3.08	0.88
epididymis, adult	10197-103E8	168.08	3.77	0.84	0.21	1.05	0.21	1.88	1.47	1.88
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	97.22	1.42	0.53	0.00	0.71	0.35	0.18	0.35	0.71
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	100.67	0.79	0.79	0.39	1.18	0.39	1.57	1.57	1.97
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	282.94	4.98	1.83	1.83	2.10	0.52	6.42	6.81	3.67
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	287.78	3.54	1.77	1.38	1.18	0.20	5.31	7.48	1.77
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	280.75	5.94	2.24	1.79	1.23	0.45	7.06	9.97	2.58
esophagus, adult, pool1	10015-101C6	169.25	6.05	0.32	0.42	0.11	0.42	1.59	1.70	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	430.94	0.50	0.50	0.38	0.13	0.13	3.01	4.88	0.25
eye - muscle inferior rectus, donor1	10272-104E2	149.70	7.24	0.00	2.41	2.41	0.00	2.41	0.00	9.66
eye - muscle lateral, donor2	10298-104H1	126.25	4.21	0.00	2.10	0.00	0.00	0.00	2.10	2.10
eye - muscle medial, donor2	10299-104H2	78.88	2.98	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	118.09	4.59	1.15	0.00	0.00	0.00	1.15	1.15	1.15
eye - vitreous humor, donor1	10268-104D7	132.62	5.83	0.00	0.00	0.00	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	200.08	6.36	0.25	1.02	0.76	1.27	1.27	1.02	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	216.19	2.05	1.67	0.13	1.03	0.64	3.33	3.72	2.18
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	205.84	3.09	0.47	0.47	1.66	0.47	2.85	0.95	1.66
frontal lobe, adult, pool1	10040-101F4	201.82	4.79	0.47	1.31	0.38	0.09	1.50	0.94	0.47
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	309.56	3.60	3.30	0.90	2.40	0.60	3.30	4.50	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	132.77	1.83	0.00	0.09	0.37	0.00	0.18	0.37	0.73
gall bladder, adult	10198-103E9	216.08	4.59	0.24	0.00	0.24	0.48	1.21	0.97	0.97
gamma delta positive T cells, donor1	11937-126A2	204.54	2.15	2.15	0.00	0.00	0.00	0.54	0.54	0.54
gamma delta positive T cells, donor2	11938-126A3	221.85	1.49	1.87	0.75	0.00	0.37	0.00	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	119.13	1.27	2.32	0.21	0.84	0.84	4.22	2.53	4.22
gastric adenocarcinoma cell line:MKN45	10612-108F9	119.53	2.13	0.19	0.39	0.58	0.19	0.58	0.58	1.93
gastric cancer cell line:AZ521	10549-107H9	359.39	2.46	1.31	0.82	0.98	0.33	6.72	4.26	0.66
gastric cancer cell line:GSS	10560-108A2	173.89	4.58	0.00	0.00	1.83	3.66	0.00	0.00	4.58
gastrointestinal carcinoma cell line:ECC12	10615-108G3	264.10	11.19	1.60	1.37	1.83	1.37	4.80	5.48	5.48
giant cell carcinoma cell line:LU65	10487-107B1	47.96	1.72	0.11	0.23	0.23	0.34	0.46	0.23	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	131.84	1.40	0.42	0.56	0.14	0.42	0.28	0.42	0.84
glassy cell carcinoma cell line:HOKUG	10688-109F4	296.56	5.74	2.00	0.75	1.50	0.75	4.99	2.74	2.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	169.62	7.71	0.32	1.27	0.00	0.32	2.01	2.11	0.63
glioblastoma cell line:A172, tech_rep2	10444-106F3	188.61	7.02	0.28	1.69	0.14	0.14	2.95	3.23	0.28
glioblastoma cell line:T98G	10485-107A8	197.24	2.54	0.77	0.33	0.55	0.77	1.66	1.32	0.77
glioma cell line:GI-1	10413-106B8	122.42	2.93	0.59	0.00	0.59	0.29	2.05	1.17	0.00
globus pallidus - adult, donor10196	10175-103C4	132.66	5.10	0.00	2.19	0.00	0.73	2.19	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	223.83	6.83	0.98	2.20	1.22	0.00	2.44	1.22	0.73
globus pallidus, adult, donor10258	10367-105F7	101.32	6.85	1.37	0.00	1.37	0.00	1.37	1.37	1.37
globus pallidus, newborn, donor10223	10364-105F4	65.02	2.13	0.00	0.00	0.00	1.07	2.66	1.07	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	247.16	0.00	0.00	0.00	0.00	0.00	2.45	2.45	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	163.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	141.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	114.88	2.56	0.32	0.32	0.32	0.32	1.92	0.96	0.64
hIPS +CCl2, biol_rep1	14383-156B9	509.62	10.10	0.46	5.51	2.75	0.92	16.53	6.43	1.84
hIPS +CCl2, biol_rep2	14384-156C1	400.56	9.15	0.91	2.29	0.00	0.46	10.52	5.03	5.03
hIPS +CCl2, biol_rep3	14385-156C2	351.03	9.66	0.64	3.86	1.93	0.64	7.73	4.51	3.22
hIPS, biol_rep1	14380-156B6	202.66	12.94	1.44	4.31	0.00	0.00	14.37	4.31	0.00
hIPS, biol_rep2	14381-156B7	353.22	5.49	1.37	1.37	1.37	0.69	10.29	5.49	4.80
hIPS, biol_rep3	14382-156B8	193.11	5.52	1.10	1.10	0.00	0.00	4.41	2.21	3.31
hairy cell leukemia cell line:Mo	10712-109I1	248.55	4.31	1.15	1.15	2.30	2.87	2.59	2.87	4.31
heart - mitral valve, adult	10205-103F7	178.78	5.08	0.60	1.20	0.90	0.30	1.49	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	187.48	5.23	0.52	0.52	0.52	0.26	1.05	0.78	0.78
heart - tricuspid valve, adult	10207-103F9	204.00	5.00	0.00	0.00	0.83	0.00	2.50	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	181.81	2.04	2.04	0.82	1.63	0.41	2.65	1.22	2.65
heart, adult, diseased, donor1	10051-101G6	111.99	5.96	3.41	0.85	2.13	0.00	0.85	0.00	0.85
heart, adult, pool1	10016-101C7	134.54	5.29	0.00	0.00	0.23	0.00	1.15	0.23	0.46
heart, fetal, pool1	10046-101G1	278.47	6.88	0.31	0.92	0.10	1.54	2.16	2.26	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	69.42	2.47	0.00	0.00	0.62	0.00	0.62	0.62	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	416.21	13.08	0.00	0.00	1.19	0.00	3.57	1.19	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	521.98	16.46	2.32	5.19	1.88	1.22	10.72	10.06	3.09
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	530.40	14.81	3.64	5.58	3.03	1.70	10.44	12.14	4.25
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	538.61	14.15	1.92	6.06	1.92	0.91	10.61	11.52	3.64
hepatoma cell line:Li-7	10484-107A7	134.46	1.22	1.11	0.33	0.56	0.11	1.22	0.33	0.67
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	574.86	8.34	2.21	2.61	1.51	1.01	11.86	16.38	3.92
hippocampus - adult, donor10196	10169-103B7	157.09	3.79	0.00	0.00	0.00	0.95	0.95	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	185.93	3.88	1.63	1.84	1.84	0.20	2.86	1.02	2.04
hippocampus, adult, donor10258	10374-105G5	100.09	3.98	1.00	1.49	0.00	0.50	2.49	0.00	2.49
hippocampus, newborn, donor10223	10363-105F3	95.52	2.47	0.70	0.00	0.00	0.35	3.17	1.76	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	830.07	28.08	9.16	3.05	5.49	1.83	14.04	18.92	12.82
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	472.82	17.87	3.73	3.93	1.77	1.57	11.19	11.98	4.32
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	525.31	19.04	3.81	1.02	0.25	1.02	4.82	14.47	4.57
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	328.17	16.92	3.38	1.69	0.56	1.13	1.69	1.69	1.69
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	387.83	22.46	26.08	2.07	6.97	3.61	4.65	4.13	11.10
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	376.95	22.40	2.66	0.76	0.76	2.28	1.90	3.04	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	326.99	4.67	1.75	0.29	1.17	0.88	3.50	3.21	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	285.66	4.52	2.37	0.00	1.08	1.29	4.95	1.94	3.02
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	259.42	4.59	1.67	0.00	0.42	0.42	3.34	2.50	1.25
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	295.99	5.68	2.84	0.47	0.95	0.95	4.50	6.16	2.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	374.79	7.23	2.89	0.64	0.96	1.77	7.55	6.43	4.50
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	269.99	4.04	0.67	0.67	0.00	0.67	8.08	4.04	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	442.85	10.33	3.60	1.56	3.60	0.47	10.17	10.02	2.97
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	494.24	10.81	14.25	3.93	4.42	1.97	12.77	8.35	18.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	610.93	17.46	6.11	2.62	6.11	2.62	12.22	17.46	5.24
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	373.80	16.61	2.86	1.53	1.15	0.57	4.20	2.29	2.67
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	324.44	16.57	2.62	0.44	1.31	1.31	4.36	4.80	3.92
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	486.27	16.49	5.50	0.50	1.50	1.50	3.00	4.50	5.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	177.09	8.48	0.94	0.19	1.32	0.94	1.13	1.51	1.32
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	170.06	3.64	2.73	0.00	0.45	0.00	2.27	0.91	1.36
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	198.28	6.58	0.63	0.00	0.00	0.94	0.31	1.25	2.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	230.58	4.25	2.45	0.65	1.63	1.14	2.29	2.45	1.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	208.15	3.48	1.16	0.00	0.29	1.16	1.74	3.19	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	226.58	5.08	2.09	0.60	1.49	0.60	1.49	3.89	0.90
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	513.96	14.96	3.33	3.33	2.77	2.77	11.27	12.56	6.65
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	456.74	17.12	2.28	3.42	1.71	0.86	9.13	15.41	2.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	778.24	19.60	5.31	3.27	5.31	1.22	14.70	22.05	8.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	342.57	19.36	4.93	1.76	1.76	1.41	5.28	2.82	5.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	254.66	12.67	0.95	0.32	1.58	1.90	4.12	3.17	2.53
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	303.53	13.92	1.21	1.51	0.91	1.51	4.24	5.14	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	192.89	4.65	1.03	0.52	1.03	0.00	1.55	2.07	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	177.33	3.32	1.99	0.00	0.00	0.66	4.65	0.66	3.98
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	216.00	6.16	1.54	0.00	0.77	1.28	2.82	1.80	2.31
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	266.39	4.09	3.32	1.28	1.28	1.79	6.39	3.07	3.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	261.24	8.33	1.51	0.00	0.76	0.76	3.03	3.79	2.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	238.26	3.36	1.68	0.34	1.68	0.34	6.39	3.70	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	520.69	14.73	3.14	2.90	1.93	0.97	13.04	14.73	3.86
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	682.75	22.73	6.24	3.57	3.57	5.35	14.71	18.27	7.13
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	542.93	13.66	2.44	1.95	2.44	1.95	7.80	14.63	4.88
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	310.20	11.31	1.53	0.31	0.61	1.53	2.75	2.75	3.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	2026.77	100.85	19.52	6.51	26.03	13.01	19.52	13.01	48.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	464.97	21.84	3.31	0.99	1.99	0.99	4.63	4.30	2.98
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	263.25	5.47	0.55	0.00	1.09	0.55	3.28	3.83	4.38
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	214.60	3.98	1.09	0.00	1.45	0.36	3.62	2.17	1.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	230.25	4.98	1.78	0.00	0.00	0.71	2.85	3.56	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	232.71	5.97	1.19	0.00	2.39	2.39	5.97	1.19	2.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	379.06	7.04	1.22	0.41	0.81	0.95	6.09	3.93	1.63
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	309.53	5.12	1.35	0.27	1.35	0.54	7.27	5.93	2.69
immature langerhans cells, donor1	11904-125F5	119.38	2.91	0.97	0.00	1.21	1.21	1.94	0.73	2.91
immature langerhans cells, donor2	11905-125F6	90.30	3.96	0.79	0.79	0.79	0.00	1.58	0.00	0.79
insula, adult, pool1	10039-101F3	211.60	6.34	0.57	1.42	0.28	0.09	1.89	0.85	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	90.07	2.60	0.33	0.65	0.33	0.00	1.63	0.00	0.33
kidney, adult, pool1	10017-101C8	165.11	4.31	0.50	0.30	0.70	0.50	0.60	1.40	0.40
kidney, fetal, pool1	10045-101F9	255.36	5.16	0.21	0.64	0.35	0.00	1.77	1.34	0.50
large cell lung carcinoma cell line:IA-LM	10509-107D5	178.38	0.71	0.28	0.14	0.14	0.00	2.70	2.13	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	75.89	1.11	0.41	0.28	0.28	0.41	0.55	0.41	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	149.55	3.49	0.18	0.37	0.37	0.37	1.28	2.02	0.55
left atrium, adult, donor1	10079-102A7	79.55	3.81	0.00	0.00	1.09	0.00	1.09	0.54	1.63
left ventricle, adult, donor1	10078-102A6	81.92	2.02	0.00	0.00	0.51	0.51	0.00	0.00	1.52
leiomyoblastoma cell line:G-402	10721-110A1	284.01	2.74	0.27	1.37	1.37	0.55	3.83	3.28	0.55
leiomyoma cell line:10964C	10569-108B2	44.91	2.16	0.36	0.00	0.00	0.36	0.36	0.72	1.44
leiomyoma cell line:15242A	10570-108B3	36.41	1.63	0.54	0.00	0.54	0.00	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	71.63	1.94	1.46	0.49	0.49	1.21	1.46	1.94	2.67
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	142.20	8.36	0.00	1.05	1.05	0.00	3.14	1.05	2.09
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	288.06	3.66	1.30	0.35	1.89	0.35	4.60	2.36	3.42
liposarcoma cell line:KMLS-1	10782-110G8	89.35	0.47	0.47	0.78	0.00	0.16	1.25	0.16	1.25
liposarcoma cell line:SW 872	10726-110A6	204.57	2.56	0.24	0.37	0.49	0.24	2.44	1.83	0.61
liver, adult, pool1	10018-101C9	136.46	4.54	0.65	0.97	0.00	0.49	1.30	1.62	0.65
liver, fetal, pool1	10086-102B5	99.72	3.76	0.94	0.00	0.94	0.94	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	155.01	9.19	0.58	2.77	0.15	0.00	2.19	0.58	0.87
locus coeruleus, adult, donor10252	10165-103B3	144.87	5.72	1.29	3.14	0.55	0.18	2.40	0.74	0.55
locus coeruleus, adult, donor10258	10375-105G6	70.82	6.49	0.28	0.28	0.56	0.56	0.56	1.13	0.56
locus coeruleus, newborn, donor10223	10362-105F2	175.40	2.94	0.00	0.84	0.42	0.42	1.68	2.94	2.52
lung adenocarcinoma cell line:A549	10499-107C4	116.25	1.11	0.14	0.55	0.00	0.42	0.97	1.11	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	120.65	2.07	0.00	0.00	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	240.43	2.37	0.40	0.26	0.66	0.66	4.35	2.11	1.58
lung, adult, pool1	10019-101D1	191.96	4.13	0.24	0.71	0.00	0.12	1.18	0.71	0.71
lung, fetal, donor1	10068-101I5	410.99	7.42	0.29	1.71	0.29	0.29	2.28	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	134.72	4.12	1.37	0.46	0.46	0.46	0.92	0.46	1.83
lymph node, adult, donor1	10077-102A5	158.58	0.95	0.95	0.00	2.37	0.47	0.95	1.42	2.84
lymphangiectasia cell line:DS-1	10727-110A7	225.31	2.19	0.66	0.88	0.44	1.10	2.85	2.19	0.88
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	224.58	4.08	1.96	0.00	0.91	0.30	4.38	2.57	3.92
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	267.59	5.95	0.00	0.85	0.85	0.00	1.70	4.25	0.00
mature adipocyte, donor1	12231-129F8	81.25	2.22	0.44	0.00	0.00	0.00	0.44	1.33	0.00
mature adipocyte, donor2	12232-129F9	59.15	3.32	0.00	0.00	0.00	0.00	0.00	0.00	0.42
mature adipocyte, donor3	12233-129G1	64.24	1.42	0.00	0.00	0.00	0.00	0.00	0.47	0.24
mature adipocyte, donor4	12234-129G2	85.81	3.69	0.00	0.00	0.26	0.26	0.53	0.53	0.53
maxillary sinus tumor cell line:HSQ-89	10414-106B9	328.80	8.58	0.48	1.91	0.00	0.00	2.86	1.91	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	165.82	7.90	0.00	1.13	0.00	1.13	3.38	1.13	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	212.60	7.54	1.29	1.84	0.55	0.00	3.49	1.29	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	112.14	2.22	0.95	0.64	0.32	0.64	0.64	0.64	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	201.73	8.10	1.28	0.43	1.28	0.43	2.99	3.84	4.69
medial temporal gyrus - adult, donor10196	10183-103D3	213.47	8.61	12.49	0.51	4.56	2.36	3.04	2.36	6.24
medial temporal gyrus, adult, donor10252	10156-103A3	227.72	6.15	1.70	0.85	1.49	0.42	1.70	1.49	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	55.86	1.93	0.00	0.00	0.00	0.00	3.85	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	976.05	0.00	0.00	14.35	0.00	0.00	0.00	0.00	14.35
medial temporal gyrus, newborn, donor10223	10353-105E2	115.58	4.67	0.00	0.36	0.00	0.00	1.79	1.44	0.00
medulla oblongata - adult, donor10196	10174-103C3	143.42	9.73	0.00	1.30	0.65	0.65	1.95	1.95	0.00
medulla oblongata, adult, donor10252	10155-103A2	167.81	4.02	1.39	1.55	0.31	0.46	1.24	0.62	0.46
medulla oblongata, adult, pool1	10038-101F2	175.17	7.92	0.24	1.96	0.24	0.24	1.31	1.55	0.24
medulla oblongata, newborn, donor10223	10361-105F1	81.59	2.78	0.35	0.00	0.35	0.00	1.04	0.00	0.69
medulloblastoma cell line:D283 Med	10838-111E1	758.34	15.28	1.33	3.32	2.21	2.44	6.64	4.65	12.18
medulloblastoma cell line:ONS-76	10759-110E3	184.88	3.55	0.86	1.10	0.49	0.00	3.30	3.18	1.22
melanoma cell line:COLO 679	10514-107E1	115.28	1.01	0.14	0.57	0.29	0.14	2.30	1.44	0.57
melanoma cell line:G-361	10465-106H6	105.87	1.63	0.81	0.81	0.81	0.27	0.54	1.09	0.81
meningioma cell line:HKBMM	10691-109F7	83.58	0.36	1.27	0.18	0.54	0.72	0.54	0.36	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	761.32	6.17	12.34	0.88	7.05	5.29	10.57	9.69	16.74
merkel cell carcinoma cell line:MS-1	10844-111E7	455.20	2.07	2.07	0.26	1.04	0.78	8.55	5.44	7.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	143.77	1.99	0.77	0.46	0.46	0.15	2.30	1.53	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	113.61	2.18	0.36	0.36	0.18	0.73	1.64	0.36	1.09
mesenchymal precursor cell - adipose, donor3	11749-123G3	62.12	1.24	0.00	0.00	0.00	0.41	2.07	2.07	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	69.54	0.56	0.56	0.56	0.56	0.14	0.70	0.70	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	73.56	1.54	1.54	0.39	0.19	0.39	1.54	0.39	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	60.38	1.39	0.69	0.00	0.00	0.00	0.00	0.69	2.78
mesenchymal precursor cell - cardiac, donor1	11752-123G6	38.45	0.86	0.51	0.00	0.34	0.00	0.00	0.17	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	74.42	1.38	0.69	0.35	0.46	0.46	1.50	0.69	0.81
mesenchymal precursor cell - cardiac, donor3	11754-123G8	131.44	0.80	0.93	0.66	0.27	0.53	1.33	1.19	1.86
mesenchymal precursor cell - cardiac, donor4	11755-123G9	106.55	0.95	0.68	0.27	0.54	0.27	1.76	2.16	1.49
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	133.44	2.13	0.57	0.57	0.43	0.28	1.99	1.99	1.42
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	65.87	0.66	0.33	0.00	0.33	0.00	0.33	0.33	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	123.70	1.66	0.28	0.42	0.28	0.42	0.83	0.83	0.97
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	88.67	1.75	1.75	0.35	0.70	0.70	1.40	0.35	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	61.86	2.65	0.82	1.43	0.61	0.00	0.20	0.82	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	56.79	2.16	0.72	0.36	0.36	0.00	0.36	0.72	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	62.79	1.45	0.41	0.41	0.52	0.31	0.31	0.41	0.31
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	34.88	0.91	0.46	0.00	0.46	0.23	0.23	0.00	0.91
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	143.07	2.52	1.26	0.42	0.42	0.84	3.36	2.52	2.94
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	96.99	0.45	0.45	0.45	0.15	0.00	1.20	0.45	0.90
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	90.42	2.01	0.18	0.61	0.35	0.09	1.75	1.14	0.79
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	52.28	2.21	0.37	0.37	0.37	0.00	0.37	0.00	0.37
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	52.37	2.58	0.57	0.57	0.57	0.57	0.29	0.57	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	215.98	1.68	6.32	0.42	5.47	2.53	3.37	3.37	7.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	90.88	1.37	0.00	0.00	0.00	0.46	0.91	0.46	1.83
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	82.62	1.28	0.26	0.26	0.51	0.00	0.77	1.02	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	80.62	0.52	0.52	0.00	0.52	0.00	1.05	0.79	1.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	82.57	2.46	0.31	0.00	0.92	0.62	0.92	0.00	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	81.20	0.94	0.71	0.24	0.00	0.24	1.65	0.00	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	90.37	2.37	0.68	0.00	0.34	0.34	1.69	0.68	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	83.70	1.57	1.18	0.00	0.00	0.39	0.79	1.18	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	83.87	2.78	0.93	0.46	0.00	0.46	0.00	0.93	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	100.66	1.73	0.58	0.29	0.29	1.44	1.44	0.87	1.73
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	90.36	0.89	0.89	0.22	0.00	0.00	0.67	1.78	0.89
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	87.97	2.40	0.48	0.96	0.72	0.00	0.96	0.72	1.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	119.53	1.47	2.93	0.73	0.00	0.73	2.93	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	81.90	0.34	0.67	0.34	0.34	0.00	1.01	0.34	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	82.29	1.64	0.41	0.00	0.82	0.00	1.23	0.41	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	85.05	1.29	0.00	0.43	0.00	0.43	1.29	0.86	1.29
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	54.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	0.00	5.16	0.00	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	61.38	0.97	0.65	0.32	0.00	0.32	0.65	0.32	1.95
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	55.29	4.36	0.00	0.00	0.00	0.00	1.45	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	45.84	1.07	1.60	0.00	0.00	0.00	0.53	0.00	1.60
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	43.34	1.64	0.00	0.00	0.82	0.00	0.00	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	52.09	0.39	0.78	0.00	0.78	0.39	1.17	0.39	3.89
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	46.17	2.10	0.00	0.00	0.00	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	43.71	0.99	1.99	0.00	0.00	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	52.44	0.00	0.00	4.77	0.00	0.00	0.00	0.00	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	52.77	1.19	0.59	0.00	0.00	0.00	0.00	1.78	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	48.74	0.00	2.44	0.00	0.00	0.00	3.66	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	27.05
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	44.34	2.53	1.27	0.00	0.00	0.63	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	41.73	0.00	0.69	0.00	0.00	0.69	0.34	0.34	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	38.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	67.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	30.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	54.19	0.41	0.81	0.00	1.22	0.41	0.81	0.41	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	51.64	0.00	0.79	0.00	0.00	1.59	0.79	0.79	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	34.19	0.59	0.00	0.00	0.59	0.00	1.18	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	46.76	0.31	0.00	0.00	0.62	0.00	0.00	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	50.79	0.00	0.00	0.00	1.34	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	70.96	0.00	0.00	0.00	1.18	0.00	1.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	89.88	2.57	5.14	0.00	0.00	0.00	0.00	0.00	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	75.04	0.69	0.00	0.00	2.07	1.38	0.69	0.69	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	57.89	1.48	0.99	0.99	0.00	0.00	1.48	0.49	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	45.98	2.24	0.00	0.00	2.24	1.12	1.12	1.12	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	51.52	0.64	0.00	0.64	0.00	0.00	0.64	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	60.45	2.82	0.40	0.00	1.21	0.00	0.40	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	67.60	0.00	2.18	0.00	0.00	2.18	0.00	4.36	6.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	45.61	2.53	0.00	1.27	0.00	0.00	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	71.61	1.82	0.00	0.00	0.00	0.61	0.61	1.21	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	72.30	0.00	0.00	0.00	0.00	0.00	0.00	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	63.42	2.47	1.65	0.82	0.00	1.65	0.82	0.82	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	37.90	0.79	0.40	0.00	0.00	0.00	0.79	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	53.22	0.65	1.30	0.00	0.00	0.32	0.65	0.65	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	58.06	3.06	2.04	0.00	0.00	0.00	0.00	0.00	3.06
mesodermal tumor cell line:HIRS-BM	10696-109G3	47.20	3.87	0.00	0.77	0.00	0.00	2.32	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	98.04	1.18	0.24	0.47	0.47	0.24	0.24	0.71	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	206.19	2.55	0.93	0.23	0.93	0.93	2.55	9.04	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	111.11	8.55	0.00	0.00	0.00	0.00	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	103.78	1.13	1.44	0.10	0.21	0.21	3.08	1.85	0.10
mesothelioma cell line:Mero-25	10850-111F4	163.63	0.91	0.68	0.68	1.13	0.68	0.68	2.50	1.59
mesothelioma cell line:Mero-41	10851-111F5	177.73	3.18	2.69	1.47	1.47	0.24	2.20	2.93	4.16
mesothelioma cell line:Mero-48a	10852-111F6	106.73	1.99	0.66	0.66	0.44	0.00	2.44	1.55	1.33
mesothelioma cell line:Mero-82	10853-111F7	217.08	1.58	4.47	1.05	2.37	2.63	7.88	6.04	6.31
mesothelioma cell line:Mero-83	10854-111F8	161.54	2.89	1.70	1.02	0.00	0.85	5.62	3.92	2.55
mesothelioma cell line:Mero-84	10855-111F9	112.74	2.27	1.26	0.25	0.51	0.00	1.52	4.04	1.52
mesothelioma cell line:Mero-95	10856-111G1	190.07	2.69	0.83	0.62	1.24	0.41	4.14	2.48	0.83
mesothelioma cell line:NCI-H2052	10847-111F1	236.88	4.64	1.49	0.99	1.16	0.66	4.14	4.31	3.64
mesothelioma cell line:NCI-H226	10846-111E9	209.59	1.99	0.54	0.90	1.99	1.09	6.52	8.33	2.90
mesothelioma cell line:NCI-H2452	10848-111F2	129.14	1.02	0.85	0.68	0.34	0.00	0.85	1.54	0.85
mesothelioma cell line:NCI-H28	10845-111E8	148.10	6.11	3.05	1.27	1.53	0.76	1.78	3.05	3.05
mesothelioma cell line:No36	10857-111G2	145.49	3.91	0.98	0.00	0.33	1.30	1.96	2.61	1.96
mesothelioma cell line:ONE58	10858-111G3	144.69	0.81	0.81	0.81	0.81	0.27	2.71	1.08	2.17
migratory langerhans cells, donor1	11901-125F2	123.60	6.33	0.19	0.19	0.77	0.38	0.38	0.58	1.54
migratory langerhans cells, donor2	11902-125F3	78.64	2.93	0.37	0.37	0.12	0.24	0.49	0.37	0.85
migratory langerhans cells, donor3	11903-125F4	75.38	2.69	0.00	0.00	0.72	0.36	0.72	0.36	0.72
mixed mullerian tumor cell line:HTMMT	10689-109F5	75.42	0.00	1.31	0.00	1.96	0.65	1.63	0.65	1.96
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	125.47	0.21	1.06	0.64	1.48	0.21	2.12	2.12	2.33
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	212.62	6.91	0.69	0.92	0.69	0.00	2.76	3.23	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	185.73	2.47	0.57	0.76	0.57	0.38	1.33	2.66	0.57
myelodysplastic syndrome cell line:SKM-1	10772-110F7	297.15	5.17	3.88	0.00	1.85	0.55	3.33	2.59	4.80
myeloma cell line:PCM6	10474-106I6	68.79	0.20	0.79	0.00	0.20	0.20	0.59	0.59	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	168.42	1.52	1.01	0.00	0.00	0.51	4.06	3.04	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	178.49	1.57	0.39	0.00	1.37	0.59	3.53	0.98	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	26.74	0.89	0.00	0.11	0.00	0.00	0.45	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	30.45	0.88	0.07	0.37	0.00	0.00	0.15	0.22	0.22
nasal epithelial cells, donor2	12227-129F4	283.17	1.10	0.00	1.66	0.55	0.00	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	473.47	3.68	1.38	0.23	1.15	0.23	5.29	1.15	1.15
neuroblastoma cell line:NB-1	10539-107G8	379.78	10.66	0.56	2.06	0.94	0.56	3.74	2.43	0.37
neuroblastoma cell line:NBsusSR	10607-108F4	190.43	1.48	1.48	0.63	0.84	0.42	0.84	2.11	2.32
neuroblastoma cell line:NH-12	10555-107I6	454.32	4.29	2.61	0.56	3.17	0.75	4.66	2.61	4.10
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	365.80	2.61	2.14	0.00	2.37	0.47	6.64	4.98	8.54
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	329.27	1.11	1.43	1.11	1.74	1.74	3.80	2.22	4.12
neuroectodermal tumor cell line:TASK1	10774-110F9	171.88	0.81	1.01	0.60	0.81	0.00	1.01	1.61	2.21
neuroepithelioma cell line:SK-N-MC	10728-110A8	360.48	2.54	0.00	1.27	1.27	1.91	3.18	5.09	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	127.49	0.80	0.53	0.27	0.27	0.53	1.86	0.80	0.53
neutrophil PMN, donor1	12133-128D9	89.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	39.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	132.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	645.36	2.20	2.88	0.51	0.85	0.68	2.37	1.35	4.23
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	129.68	8.01	0.80	0.80	0.00	0.00	1.60	0.80	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	84.96	0.64	0.32	0.00	0.64	0.00	2.89	0.64	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	85.66	2.63	0.53	0.26	0.26	0.00	0.79	0.53	1.31
nucleus accumbens, adult, pool1	10037-101F1	197.04	5.44	0.19	0.47	0.56	0.47	1.41	0.94	0.47
occipital cortex - adult, donor10196	10172-103C1	245.19	10.30	0.00	0.00	2.06	0.00	6.18	0.00	4.12
occipital cortex, adult, donor10252	10163-103B1	222.20	6.71	0.81	2.95	1.07	0.27	3.49	0.27	1.61
occipital cortex, newborn, donor10223	10355-105E4	107.36	7.64	0.00	0.73	0.36	0.00	2.91	1.46	0.36
occipital lobe, adult, donor1	10076-102A4	143.01	4.20	0.79	0.00	1.05	1.57	2.89	0.79	2.89
occipital lobe, fetal, donor1	10073-102A1	239.87	5.15	1.29	0.00	4.72	1.29	5.15	3.43	6.87
occipital pole, adult, pool1	10036-101E9	165.41	4.34	0.16	0.47	0.08	0.16	1.50	0.79	0.16
olfactory region, adult	10195-103E6	164.30	5.73	0.38	1.34	1.15	0.57	2.87	1.34	1.91
optic nerve, donor1	10277-104E7	188.10	20.01	0.00	0.00	0.00	0.00	0.00	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	147.74	1.94	0.34	0.46	0.34	0.34	1.25	0.91	1.48
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	219.96	1.79	0.27	0.41	0.41	0.00	0.69	1.24	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	146.30	1.52	2.03	0.17	0.51	0.34	2.88	1.69	2.88
oral squamous cell carcinoma cell line:SAS	10544-107H4	205.37	2.43	0.81	0.46	1.04	0.69	4.97	2.77	2.19
osteoclastoma cell line:Hs 706.T	10704-109H2	97.01	1.47	0.00	0.00	0.00	0.59	0.88	0.29	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	244.80	10.28	0.00	0.00	0.00	0.00	3.74	2.80	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	195.31	2.76	0.21	0.21	0.42	0.42	4.45	2.33	1.70
ovary, adult, pool1	10020-101D2	274.46	5.59	0.52	0.87	0.17	0.26	1.31	1.57	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	132.36	2.38	0.18	0.55	0.92	0.37	1.47	1.47	0.55
pancreas, adult, donor1	10049-101G4	168.37	2.82	2.82	0.00	1.88	0.00	1.88	1.88	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	278.70	1.96	0.56	0.84	1.12	1.12	5.59	5.59	0.84
papillary adenocarcinoma cell line:8505C	10437-106E5	120.44	1.02	2.38	0.34	0.51	1.19	1.36	0.85	3.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	208.14	2.98	0.50	0.17	0.33	0.50	0.99	1.66	0.66
paracentral gyrus, adult, pool1	10035-101E8	184.14	4.30	0.18	1.10	0.18	0.18	1.65	0.92	0.46
parietal cortex, adult, donor10258	10373-105G4	253.97	2.20	1.47	0.00	2.20	0.00	4.40	1.47	0.00
parietal lobe - adult, donor10196	10171-103B9	183.39	5.64	0.94	0.00	0.94	0.94	0.94	0.94	0.94
parietal lobe, adult, donor10252	10157-103A4	206.37	6.84	1.71	0.57	1.14	0.86	3.71	0.86	2.00
parietal lobe, adult, pool1	10034-101E7	166.63	4.14	0.26	1.76	0.26	0.09	0.44	1.50	0.26
parietal lobe, fetal, donor1	10072-101I9	358.84	2.91	4.85	0.97	3.88	1.94	6.79	2.91	4.85
parietal lobe, newborn, donor10223	10356-105E5	114.40	7.48	0.00	0.00	0.75	0.37	2.62	0.37	0.00
parotid gland, adult	10199-103F1	240.50	9.25	0.00	1.23	0.00	2.47	1.85	0.00	1.85
penis, adult	10200-103F2	186.38	5.91	2.69	0.00	3.22	2.15	1.07	0.00	2.69
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	126.25	2.05	0.93	0.37	0.37	0.19	0.56	0.74	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	144.38	1.46	0.87	0.15	1.17	0.15	1.17	1.02	1.89
pineal gland - adult, donor10196	10179-103C8	227.69	9.03	0.00	1.29	0.65	0.00	2.58	1.94	1.94
pineal gland, adult, donor10252	10160-103A7	222.67	14.81	1.78	1.18	0.59	0.59	3.55	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	174.33	9.41	0.00	0.63	0.00	1.25	3.76	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	280.27	16.19	2.02	0.00	3.04	0.00	3.04	4.05	3.04
pituitary gland, adult, donor10252	10162-103A9	345.02	9.90	1.04	2.08	2.08	0.00	1.56	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	183.87	6.81	0.00	2.55	1.70	0.00	0.00	0.85	0.85
placenta, adult, pool1	10021-101D3	214.36	3.23	0.43	0.65	0.00	0.22	1.51	2.04	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	378.61	4.11	1.46	0.40	1.19	0.40	2.91	3.18	4.37
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	86.22	2.33	0.31	0.16	0.00	0.00	0.93	0.31	0.62
pons, adult, pool1	10033-101E6	155.95	6.97	0.69	2.15	0.17	0.17	1.12	1.03	0.17
postcentral gyrus, adult, pool1	10032-101E5	177.40	4.97	0.52	0.78	0.44	0.26	1.74	0.78	0.35
promyelocytes/myelocytes PMC, donor1	12132-128D8	230.05	4.18	0.00	0.00	0.00	0.00	6.27	6.27	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	126.68	5.51	0.00	0.00	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	129.09	0.00	0.00	0.00	0.00	0.00	0.00	11.74	0.00
prostate cancer cell line:DU145	10490-107B4	218.93	2.33	1.75	0.87	1.02	0.58	1.46	2.48	1.89
prostate cancer cell line:PC-3	10439-106E7	250.29	5.45	0.91	1.63	1.27	0.18	2.00	2.18	0.91
prostate, adult, pool1	10022-101D4	206.87	3.36	0.00	0.00	0.27	0.27	1.81	0.63	0.27
putamen, adult, donor10196	10176-103C5	262.27	2.36	2.60	0.94	0.94	0.71	8.03	2.12	1.42
putamen, adult, donor10252	10152-102I8	70.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	148.62	5.46	1.09	1.09	0.00	1.09	3.28	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	126.12	1.69	0.97	0.24	1.45	1.21	2.42	0.97	0.97
putamen, newborn, donor10223	10365-105F5	155.18	3.75	0.75	0.75	0.00	0.75	3.00	4.50	1.50
rectal cancer cell line:TT1TKB	10469-106I1	156.52	4.95	0.00	0.29	0.00	0.29	1.16	1.75	0.00
rectum, fetal, donor1	10067-101I4	210.04	1.39	1.39	0.00	2.78	0.00	1.39	1.39	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	88.40	3.39	1.27	0.42	0.42	0.42	0.21	0.42	1.70
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	114.74	1.24	1.24	0.00	0.41	0.00	0.41	0.00	3.73
retina, adult, pool1	10030-101E3	230.11	11.23	0.50	0.70	0.40	0.30	1.69	0.89	0.50
retinoblastoma cell line:Y79	10475-106I7	538.83	15.59	4.42	1.82	2.60	1.04	11.17	7.79	7.27
rhabdomyosarcoma cell line:KYM-1	10787-110H4	329.01	3.93	0.98	2.34	2.34	1.23	5.53	6.27	2.09
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	652.67	4.22	0.84	1.41	1.12	0.28	7.31	6.19	1.69
sacrococcigeal teratoma cell line:HTST	10695-109G2	137.93	3.03	0.00	0.76	0.76	0.00	0.00	3.79	0.00
salivary acinar cells, donor1	11771-123I7	147.45	0.81	0.32	0.00	0.32	0.16	1.13	0.97	1.46
salivary acinar cells, donor2	11772-123I8	154.35	0.14	1.24	0.14	0.41	0.69	1.24	0.28	2.34
salivary acinar cells, donor3	11773-123I9	151.61	7.28	0.00	0.66	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	167.01	8.01	0.00	1.14	0.00	0.00	0.57	2.86	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	77.15	0.42	0.17	0.25	0.17	0.00	0.42	0.42	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	96.04	0.59	0.71	0.24	0.35	0.00	0.59	0.24	0.59
seminal vesicle, adult	10201-103F3	226.44	6.35	1.06	0.00	3.17	2.12	1.59	1.59	3.17
serous adenocarcinoma cell line:JHOS-2	10639-108I9	84.54	4.62	0.24	1.21	1.21	1.21	1.46	0.73	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	60.39	5.03	0.75	0.25	0.00	0.25	0.75	0.25	1.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	185.65	7.02	1.00	0.00	1.00	2.01	0.00	4.01	3.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	154.74	2.01	1.21	0.13	1.21	0.81	3.49	2.82	1.48
signet ring carcinoma cell line:Kato III	10436-106E4	119.92	1.88	0.44	0.88	0.11	0.22	1.33	1.88	0.88
signet ring carcinoma cell line:NUGC-4	10483-107A6	190.31	4.90	0.65	0.39	0.52	0.13	3.74	3.10	1.03
skeletal muscle - soleus muscle, donor1	10282-104F3	119.17	12.06	1.42	2.13	1.42	0.71	0.00	2.13	0.71
skeletal muscle, adult, pool1	10023-101D5	161.44	6.48	0.00	0.24	0.12	0.12	0.48	0.24	0.36
skeletal muscle, fetal, donor1	10066-101I3	156.78	3.02	2.01	1.01	2.01	1.01	1.01	0.00	3.02
skin, adult, donor1	10074-102A2	128.92	0.00	6.79	0.00	0.00	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	176.11	3.79	0.00	0.63	2.52	1.89	1.89	1.26	5.05
small cell cervical cancer cell line:HCSC-1	10800-110I8	302.17	3.34	1.00	1.00	1.67	1.67	5.00	5.67	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	417.02	10.40	2.84	1.89	3.47	0.32	11.66	1.89	4.41
small cell lung carcinoma cell line:DMS 144	10841-111E4	244.21	4.05	0.39	0.58	0.39	1.35	3.85	1.93	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	461.85	5.93	0.49	1.65	0.66	0.49	5.44	3.30	0.99
small cell lung carcinoma cell line:NCI-H82	10842-111E5	446.36	25.09	0.48	3.38	2.41	0.64	1.77	0.97	4.18
small cell lung carcinoma cell line:WA-hT	10562-108A4	229.90	2.40	0.65	0.00	0.87	0.00	5.88	2.62	1.74
small intestine, adult, pool1	10024-101D6	266.95	6.21	0.72	0.96	0.36	0.12	2.03	1.67	0.36
small intestine, fetal, donor1	10064-101I1	247.42	7.37	1.97	0.25	2.21	1.47	4.42	1.23	4.18
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	122.07	2.56	0.51	0.51	1.03	1.03	2.56	1.54	8.21
smooth muscle, adult, pool1	10048-101G3	198.75	3.62	0.52	1.03	1.29	0.78	4.91	1.03	2.58
somatostatinoma cell line:QGP-1	10781-110G7	155.45	9.11	0.00	0.54	0.80	0.80	2.95	0.27	0.00
spinal cord - adult, donor10196	10181-103D1	148.43	8.03	3.44	2.52	0.69	0.46	1.38	0.69	1.84
spinal cord, adult, donor10252	10159-103A6	160.86	3.15	0.79	1.18	0.00	0.79	1.58	0.39	0.39
spinal cord, adult, donor10258	10369-105F9	152.20	5.53	0.00	0.69	0.00	0.00	3.46	0.69	0.69
spinal cord, fetal, donor1	10056-101H2	194.54	6.10	2.44	0.61	1.22	0.00	2.44	0.00	3.66
spinal cord, newborn, donor10223	10359-105E8	130.88	4.59	2.76	0.00	0.00	0.00	1.38	1.84	2.30
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	119.33	2.69	0.45	0.75	0.45	0.15	2.84	1.19	0.60
spleen, adult, pool1	10025-101D7	265.97	2.42	0.88	0.33	0.33	0.44	1.10	1.54	0.66
spleen, fetal, pool1	10044-101F8	255.77	3.10	0.32	0.72	0.24	0.32	1.83	1.27	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	223.17	1.86	2.28	0.31	0.41	0.52	2.07	4.55	1.86
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	163.48	2.09	0.19	0.38	0.19	0.19	0.38	0.19	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	345.61	4.54	4.89	0.35	2.80	1.05	7.69	6.29	7.69
squamous cell carcinoma cell line:T3M-5	10616-108G4	143.47	3.52	0.39	0.39	0.78	0.39	4.30	1.56	0.39
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	156.23	2.93	0.79	0.45	0.45	0.34	1.24	1.46	0.90
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	124.54	1.27	0.85	0.42	0.85	0.00	1.69	1.27	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	150.61	3.38	0.42	0.00	0.85	0.85	0.85	2.12	2.12
stomach, fetal, donor1	10062-101H8	346.02	5.34	0.00	1.07	1.07	0.00	2.14	1.07	2.14
submaxillary gland, adult	10202-103F4	169.76	6.84	1.71	0.00	0.57	1.71	0.00	1.14	1.71
substantia nigra - adult, donor10196	10178-103C7	271.37	54.27	108.55	0.00	0.00	0.00	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	146.23	3.53	0.62	0.83	0.62	0.42	1.25	1.04	1.25
substantia nigra, adult, donor10258	10371-105G2	108.11	4.14	0.00	0.52	0.00	0.00	2.59	0.00	2.59
substantia nigra, newborn, donor10223	10358-105E7	75.60	1.41	0.00	0.00	0.00	0.71	0.00	1.41	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	259.76	2.75	2.29	0.23	0.92	1.83	3.90	3.90	2.06
temporal lobe, adult, pool1	10031-101E4	173.95	5.43	0.51	0.59	0.42	0.17	2.54	0.76	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	382.49	4.99	3.56	0.00	4.27	1.42	8.55	5.70	5.70
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	288.78	5.71	3.52	0.00	1.32	0.88	6.59	2.64	9.67
tenocyte, donor1	11763-123H8	168.27	2.44	2.44	1.05	1.75	0.35	3.49	0.00	4.19
tenocyte, donor2	11765-123I1	85.08	1.14	1.14	0.00	0.38	0.00	3.05	0.00	1.91
tenocyte, donor3	11768-123I4	89.33	1.11	1.11	0.37	2.97	0.74	1.48	0.37	3.34
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	455.66	20.91	2.21	8.50	1.53	2.21	8.67	10.88	3.91
teratocarcinoma cell line:NCR-G1	10798-110I6	359.32	6.47	1.23	1.54	0.92	0.62	7.24	5.55	2.93
teratocarcinoma cell line:PA-1	10807-111A6	383.72	11.78	1.24	3.25	1.39	1.24	6.66	4.65	3.25
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	317.75	9.90	1.27	4.06	1.14	0.25	11.04	13.84	2.79
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	374.01	11.72	1.89	0.76	1.13	0.38	4.16	3.78	4.16
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	282.25	11.02	0.55	2.84	0.55	0.22	4.25	3.16	1.31
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	463.80	16.29	6.19	2.93	2.93	2.93	4.89	11.40	7.82
testis, adult, pool1	10026-101D8	189.41	10.74	0.32	0.64	0.21	0.21	1.93	1.40	0.32
testis, adult, pool2	10096-102C6	191.71	26.16	3.16	3.16	1.35	0.90	2.71	2.71	5.41
thalamus - adult, donor10196	10168-103B6	185.47	7.73	0.00	1.10	1.10	0.00	1.10	0.00	1.10
thalamus, adult, donor10252	10154-103A1	180.66	3.59	1.41	0.94	0.94	0.16	1.72	1.41	1.09
thalamus, adult, donor10258, tech_rep1	10370-105G1	41.57	6.16	0.00	1.54	0.00	0.00	1.54	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	46.28	1.81	0.82	0.16	0.49	0.16	0.49	0.16	0.49
thalamus, newborn, donor10223	10366-105F6	96.65	4.03	0.58	0.00	1.15	0.58	1.15	1.73	0.58
throat, adult	10209-103G2	164.53	4.74	1.25	0.25	0.50	0.50	1.00	0.50	3.99
throat, fetal, donor1	10061-101H7	224.26	4.88	2.13	0.91	0.91	0.30	2.13	1.22	2.44
thymic carcinoma cell line:Ty-82	10803-111A2	338.84	2.98	0.60	0.00	0.99	0.99	7.95	4.17	3.18
thymus, adult, pool1	10027-101D9	645.30	6.66	1.39	0.40	0.60	0.89	10.54	7.36	1.59
thymus, fetal, pool1	10043-101F7	480.56	3.64	0.73	0.42	1.14	0.83	6.13	5.09	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	191.86	3.46	0.40	0.40	0.53	0.13	3.72	3.06	1.33
thyroid carcinoma cell line:TCO-1	10783-110G9	206.32	2.10	0.42	0.56	0.70	0.98	3.35	2.10	0.98
thyroid, adult, pool1	10028-101E1	195.30	2.71	0.47	0.37	0.09	0.28	1.31	1.03	0.37
thyroid, fetal, donor1	10060-101H6	206.18	3.16	1.32	0.26	2.90	0.53	2.11	1.85	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	194.02	6.16	0.00	3.08	0.00	0.00	3.08	3.08	0.00
tongue, adult	10203-103F5	202.57	7.91	1.40	1.16	0.93	0.70	3.02	0.93	2.33
tongue, fetal, donor1	10059-101H5	183.65	5.12	0.79	0.79	1.97	1.18	2.36	1.58	2.36
tonsil, adult, pool1	10047-101G2	332.38	6.41	0.80	1.30	0.60	0.20	2.10	2.40	0.40
trachea, adult, pool1	10029-101E2	199.34	5.89	0.25	0.16	0.16	0.08	1.72	0.74	0.57
trachea, fetal, donor1	10058-101H4	206.58	3.08	0.00	1.15	0.00	0.00	1.15	0.00	1.15
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	161.20	2.83	1.06	0.00	1.06	2.13	2.83	2.48	1.06
transitional-cell carcinoma cell line:5637	10418-106C4	233.13	4.05	0.51	0.61	0.20	0.30	2.23	3.34	0.81
transitional-cell carcinoma cell line:JMSU1	10492-107B6	405.98	2.51	3.45	1.25	1.25	0.78	2.66	2.51	3.13
tridermal teratoma cell line:HGRT	10694-109G1	245.43	7.61	0.00	1.90	1.90	0.00	0.00	1.90	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	157.11	1.27	0.34	0.17	0.34	0.17	1.69	0.59	1.19
umbilical cord, fetal, donor1	10057-101H3	141.88	0.00	0.00	2.09	2.09	0.00	2.09	0.00	6.26
uterus, adult, pool1	10100-102D1	246.56	3.92	0.17	0.17	0.00	0.00	2.05	1.71	0.34
uterus, fetal, donor1	10055-101H1	266.20	4.10	2.05	0.00	3.07	0.00	2.05	1.54	1.54
vagina, adult	10204-103F6	163.49	3.23	0.00	0.00	0.65	0.65	1.94	0.00	0.00
vein, adult	10191-103E2	242.43	2.85	1.32	0.22	1.32	0.66	2.19	1.75	3.51
xeroderma pigentosum b cell line:XPL 17	10563-108A5	186.66	1.34	1.87	0.27	1.07	0.00	2.14	1.34	4.01